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Neonatal hypoglycemia is the most common metabolic abnormality in infants and is 
associated with neurological damage and death. The risk of developing hypoglycemia among 
infants born from diabetic mothers is even higher. Although much work has been performed 
addressing issues for treatment and care, research related to neonatal hypoglycemia has been 
focused on the clinical or individual level risk factors. Contextual risk factors such as hospital 
characteristics, neighborhood economic status, and regional variations were not considered in 
earlier studies. Additionally, although healthcare resources utilization of hypoglycemia has been 
adequately addressed in the adult population, this topic has not been studied in hypoglycemic 
neonates. 
The overarching purpose of this dissertation was to investigate healthcare outcomes and 
resource utilization related to neonatal hypoglycemia. The first purpose was to conduct a 
systematic review in order to investigate whether previous studies only focused on clinical risk 
factors or included a broader health service-related contextual risk factors in assessing the 
determinants of neonatal hypoglycemia. The second purpose was to identify the key factors 
associated with increased hospital cost associated with neonatal hypoglycemia in the United 
States. The third and final purpose of the dissertation was to construct multi-level models that 




The systematic review (Project I) determined that previous studies mainly focus on the 
clinical characteristics of infants and mothers. The systematic review suggested that contextual 
variables should be included in future research. Project II found that increased cost was 
observed, when more than five procedures were performed during the same hospitalization, 
when hospital bed size was between 100 and 300 or ≥ 400, when hospital length of stay 
exceeded 15 days, in teaching hospitals, in the presence of chronic conditions, comorbidities, 
prematurity, and death. In project III we found that infant of diabetic mothers had more than 5-
fold increased risk of developing neonatal hypoglycemia compared to infants of non-diabetic 
mothers. Infants born in urban and teaching hospitals also had significantly higher chance of 
developing neonatal hypoglycemia. Project III also determined that the inclusion of the 
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Health services research, among other things, examines determinants of health outcomes, 
healthcare cost, and quality of care usually at the population level and may investigate parts or 
the entire spectrum of care.1,2 One important aspect is understanding the healthcare outcomes and 
efficient utilization of resources by including a broader spectrum of influencing factors. For 
neonatal hypoglycemia, although much work has been performed addressing issues for treatment 
and care3 research in the area has been focused on the clinical determinants of the condition. 
Before discussing these issues in further detain, a synopsis of what neonatal hypoglycemia is and 
how it affects the newborn’s health is warranted.   
Neonatal hypoglycemia is the most frequently encountered metabolic disorder of 
newborn infants and has been linked to various adverse health outcomes.4,5 Hypoglycemia is a 
metabolic abnormality in neonates due to inability to maintain glucose homeostasis.6-8 Glucose is 
an essential primary substrate for the brain and its consumption by the brain is high and as a 
result, neurons and glial cells are susceptible to hypoglycemia.9-15 Therefore, glucose 
homeostasis is crucial for the overall physical and neurological development of newborns.6 
Throughout gestation, maternal glucose provides all the glucose for the fetus via facilitated 
diffusion across the placenta according to a maternal-to-fetal glucose concentration gradient.1,6 
Hypoglycemia in neonates has been recognized as a cause of serious short-term and long-term 
morbidity for over 50 years.16 Several clinical conditions could be associated with neonatal stress 
that could affect glucose homeostasis including infection, asphyxia, congenital heart disease, 





restriction, islet cell hyperplasia, erythroblastosis fetalis, and Beckwith-Wiedemann 
Syndrome.4,17-21 In addition, endocrine abnormalities such as pan-hypopituitarism, 
hypothyroidism, adrenal insufficiency, increased glucose utilization, sepsis, and perinatal 
asphyxia could also be associated with neonatal hypoglycemia.17,22 Although in most of these 
neonates, hypoglycemia is transient and asymptomatic, unrecognized hypoglycemia may lead to 
neonatal seizures, coma, and neurologic injury.23,24 Prolonged neonatal hypoglycemia may also 
cause neuroglycopenic signs such as seizure, coma, cyanotic episodes, apnea, bradycardia or 
respiratory distress, and hypothermia.4,22 
The risk of developing hypoglycemia among infants born from diabetic mothers is even 
higher.25-32 Although the predisposing risk factors for the development of neonatal hypoglycemia 
in diabetic pregnancies are thought to be mainly related to poor maternal glycemic control, 
neonatal weight at birth, and gestational age at delivery37,38, the full extent of the individual and 
contextual risk factors remains unclear.  Previous studies of neonatal hypoglycemia15,17-27,39-42 
mainly focused on clinical risk factors such as poor maternal glycemic control, neonatal weight 
at birth, and gestational age at delivery as predisposing risk factors for neonatal hypoglycemia in 
diabetic pregnancies. However, contextual risk factors such as neighborhood socioeconomic 
status, hospital characteristics, and regional variations were not considered in these studies. 
Therefore, it is important to identify the various levels of risk factors that can predict neonatal 
hypoglycemia in this vulnerable population.   
In addition to leading to serious acute1,4 and chronic health problems43, neonatal 
hypoglycemia also consumes a considerable amount of healthcare resources4. Although 
healthcare resource utilization of hypoglycemia has been adequately addressed in the adult 





increase in the overall healthcare cost in the United States, there is a strong interest to enhance 
efficacy through reform and system improvement.51,51 A better understanding of factors 
associated with healthcare resource utilization such as hospitalization cost and length of stay for 
neonates with hypoglycemia may help hospitals improve the efficiency of the care they provide 
while maintaining high quality of care.  
Statement of the Problem  
 
Estimates for neonatal hypoglycemia are between 3% and 29% of all pregnancies in the 
United States.1,26 The risk of developing hypoglycemia among infants born from diabetic 
mothers is even higher.25-32 Hypoglycemia occurs in approximately 8-30% of neonates born to 
mothers with diabetes33,34, with an estimated incidence rate of approximately 27% among infants 
born to women with diabetes compared to 3% among apparently healthy full-term infants born to 
nondiabetic women.12-13 Previous studies15,17-27,39-42 mainly focused on clinical risk factors 
without considering the contextual risk factors for the development of neonatal hypoglycemia. In 
addition to leading to serious acute4 and chronic health problems43, neonatal hypoglycemia also 
consumes a considerable amount of healthcare resources.52 With this overarching problem, this 
dissertation plans to address three problem areas that will be carried out with three interrelated 
but independent research projects.  
Problem 1 
Although the predisposing risk factors for the development of neonatal hypoglycemia in 
diabetic pregnancies are thought to be mainly related to poor maternal glycemic control, neonatal 
weight at birth and gestational age at delivery 37,38, the full extent of individual and contextual 
level determinants of neonatal hypoglycemia remain unclear. For health services research, it is 





included broader contextual risk factors in assessing the determinants of neonatal hypoglycemia. 
Conducting the systematic review on the topic will examine, collate, and synthesize the current 
collective evidence on the subject matter.  
Problem 2 
Although healthcare resource utilization of hypoglycemia has been adequately addressed 
in the adult population44-49, this topic has not been studied in neonates with hypoglycemia. 
Therefore, identifying predictors of hospital cost estimates associated with neonatal 
hypoglycemia is important for efficient allocation of resources. Additionally, most cost estimate 
studies use total hospital charge as a proxy measurement for actual cost.53 This may lead to 
drawing unwarranted conclusions about efficiency in hospital resource utilizations.53 Therefore, 
using actual cost is important to accurately identify factors associated with increased hospital 
cost related to neonatal hypoglycemia.  
In this regard, the Kids’ Inpatient Database provides a separate cost-to-charge-ratio data 
file that will enable us to convert total hospital charge to total cost.54 This will maximize the 
accuracy of the hospital cost estimation at the national level. Identifying the key factors 
associated with increased hospital cost is important to improve health outcomes and minimize 
hospitalization costs in these priority populations. To date, no study has been conducted to 
estimate hospitalization cost and identify predictors related to neonatal hypoglycemia.  
Problem 3 
Neonates with hypoglycemia are prone to different acute37 and chronic health problems.43 
In the short run, newborns may experience jitteriness, hypotonia, lethargy, irritability, apnea, 
tachypnea, poor feeding, hypothermia, and seizures.55 Later in their life, they may experience a 





infants born from diabetic mothers is even higher.35,56 Research in this topic15,17-27,39-42 mainly 
focused on clinical risk factors such as poor maternal glycemic control, neonatal weight at birth, 
and gestational age at delivery as predisposing risk factors for the development of neonatal 
hypoglycemia in diabetic pregnancies. However, contextual risk factors such as neighborhood 
socioeconomic status, institutional characteristics, and regional variations were not considered in 
these studies. Due to lack of adequate knowledge about the potential individual and contextual 
level risk factors, the prevention of neonatal hypoglycemia has been difficult.57As a health 
service researcher, one should consider the contextual risk factors that has not been included in 
previous neonatal hypoglycemia research. Therefore, using multilevel models that include 
individual (demographic and clinical characteristics of mothers and infants) level and contextual 
(neighborhood, institutional characteristics, and regions) level characteristics in order to predict 
neonatal hypoglycemia is warranted. 
Purpose of the Study  
 
 The dissertation will address the three identified problems described above. Accordingly, 
the first objective was to conduct a systematic review in order to investigate whether previous 
studies only focused on clinical risk factors or included a broader health service-related 
contextual risk factors in assessing the determinants of neonatal hypoglycemia. The second 
objective was to estimate hospitalization cost and identify the key factors associated with 
increased hospital cost associated with neonatal hypoglycemia in the United States. The third and 
final objective of the dissertation was to construct multi-level models that include individual-
level and contextual-level characteristics in order to predict neonatal hypoglycemia in diabetic 






The Social Ecological Model 
This dissertation will apply the social ecological model which captures several layers of 
factors that include the infant’s biology, his/her immediate family/community environment, and 
the societal landscape that affects his/her development.58 Therefore, to understand the numerous 
risk factors for a particular disease that affects an infant, these layers of the larger contextual or 
distal factors has to be considered in addition to the immediate individual or proximal level 
factors. The social ecological model was originally developed by Urie Bronfenbrenner over the 
span of several years.58-61 However, Kenneth McLeroy59 and Daniel Stokols60 have also made 
significant contributions to the development of the social ecological model by applying it to 
other health-related topics such as health behaviors and health promotion. 
Although the social ecological model has not been applied to the identification of risk 
factors associated with neonatal hypoglycemia, it has been widely used in several public health 
and epidemiological research and practice. This includes reproductive health65, health education, 
and promotion66, environmental health66, violence prevention67, chronic diseases such as 
obesity68 and diabetes.69 As practiced in these studies, while keeping the major components of 
the model, necessary modifications will be made to fit the current topic. 
The original social ecological model developed by Bronfenbrenner58 has five major 
components that include microsystem, mesosystem, exosystem, macrosystem, and 
chronosystem. These constitute the ecological environment which is conceived as a set of nested 
structure, each inside the next.58 According to the theory, microsystem indicates the immediate 
environment that proximal processes operate to produce and sustain the child’s development.58,59 
In the dissertation, demographics, clinical, and laboratory measures are considered to be the 





comprises the linkage and process taking place between two or more settings such as the 
relationship between a mother and her child.58,61 For example, the mother’s health directly 
affects the health of a newborn child. Hypoglycemic neonates born from diabetic mothers are at 
higher risk than those born from non-diabetic mothers mainly because of the poor health 
condition of the mother.35,56 Exosystem comprises the linkages and processes taking place in two 
or more settings, at least one of which does not contain the developing person, but in which 
events occur that indirectly influence processes within the immediate setting in which the 
developing person lives.58 The exosytem considered in this dissertation are neighborhood and 
hospital characteristics that may affect neonates with hypoglycemia. Macrosystem indicates 
policy and societal culture that ultimately affect the particular conditions and process occurring 
in the development of a child.59-62 As indicated in Figure I.1, regional variations and 
neighborhood socio-economic status are considered to be the macrosystem. The chronosystem 
encompasses change or consistency over time not only in the characteristics of the child but also 
in the environment in which the child lives.62 Since time is not considered in the dissertation, we 
will only be focusing on the first four factors of the ecological model.  
In the case of neonatal hypoglycemia, because of the intertwined relationship between the 
health of the mother and the newborn, the microsystem and mesosystem are classified as 
individual level characteristics (Figure I.1). Similarly, as exosystem and macrosystem are 
interrelated, the two systems are classified as contextual level characteristics. Therefore, in our 
current analysis, the two levels of characteristics will be examined. By combining both the 
individual and contextual level characteristics, we propose to build multilevel models that can 





mothers. As indicated in Figure I.1, the overlapping elliptical circles in the model illustrate how 
factors at one level influence factors at another level.   
The application of such conceptual framework will enhance the current research in 
neonatal hypoglycemia by providing a broader perspective of the risk factors that were 
previously limited to clinical or individual level risk factors. In addition, the application of 
multilevel models, through taking complex survey design into consideration, will promote the 
use of advanced statistical methodologies in other areas of health outcomes research in the 
pediatric population. 
Significance of the Study  
 
For neonates to have a normal brain, adequate supply of glucose during infancy is 
crucial.70 Therefore, the lack of this essential substrate at the early stage of growth may lead to 
various acute4 and long term43 life-threatening medical conditions. Specific groups of newborn 
infants, including infants having prematurity, macrosomia, intrauterine growth restriction, 
maternal diabetes, and sepsis, are at increased risk for hypoglycemia.14,35,36 Neonatal 
hypoglycemia is a highly preventable medical condition71 and yet it poses a significant threat to 
the health of newborns. Due to lack of adequate knowledge about the potential individual and 
contextual level risk factors, the prevention of neonatal hypoglycemia has been difficult.57 
Considering these multilevel characteristics in assessing the predictors for neonatal 
hypoglycemia is necessary to understand the complex interaction among various individual and 
contextual level factors that determine neonatal hypoglycemia. In addition, since neonatal 
hypoglycemia is strongly associated with diabetic pregnancies33,72,73, the identification of the risk 
factors will also have important implications on mothers’ health through effective prevention 





research will guide the prevention and control of adverse health outcomes associated with 
hypoglycemia in these priority populations.    
The use of a conceptual framework to identify predictors of neonatal hypoglycemia is 
also lacking in current research on the topic. Although the primary objective of the current 
dissertation is not to test a theory, the use of social ecological model58,63,64 as a conceptual 
framework will help us understand the complex influencing factors associated with neonatal 
hypoglycemia. The social ecological model defines complex layers of factors that affect the 
development of a child. That is the interaction between factors in the child’s biology, his/her 
immediate environment and the societal landscape affecting his/her development. Using a 
conceptual framework in health outcomes research is a vital tool to insure that all essential risk 
factors are considered.74 
Identifying predictors of hospital cost associated with neonatal hypoglycemia is 
important for efficient utilization and allocation of healthcare resources. However, healthcare 
resource utilization of hypoglycemia has only been studied in adult populations.26-34 
Furthermore, most cost estimate studies have used total hospital charge as a proxy measurement 
for actual cost.53 However, this may lead to drawing unwarranted conclusions about economic 
efficiency and hospital resource utilizations.53 Project II of the dissertation seeks to determine the 
predictors of hospital cost estimates by using actual cost rather than using hospital charges as a 
proxy for cost. In this regard, the Kids’ Inpatient Database provides a separate cost-to-charge-
ratio data file that will enable us to convert total hospital charge to total cost54. This will 
maximize the accuracy of the cost estimation at the national level. Identifying the key factors 
associated with increased hospital cost is important to improve health outcomes and minimize 





Overall, the results of this dissertation are expected to improve scientific knowledge 
through the identification of multiple levels of risk factors based on a conceptual framework and 
appropriate application of rigorous statistical methodologies. Additionally, we anticipate that the 
proposed work will improve prevention of neonatal hypoglycemia and promote efficient 
utilization of hospital resources. The studies included in this dissertation were conducted in 
compliance with the institutional review board. 
Specific Aims and Hypotheses  
 
Aim 1: To conduct a systematic review in order to investigate whether previous studies only 
focused on clinical risk factors or included a broader health service-related contextual risk 
factors in assessing the determinants neonatal hypoglycemia.  
Hypotheses 1: In the literature, all studies will focus on the individual level characteristics 
as determining risk factors for neonatal hypoglycemia.   
Aim 2: To determine the overall hospital cost estimates and identify predictors of increased 
hospital cost in neonates with hypoglycemia.  
Hypotheses 2.1: Healthcare outcome measures including length of stay, comorbidities, 
mortality, prematurity, number of procedures, hospital bed size, chronic conditions, and 
hospital teaching status will predict increased hospital cost associated with neonatal 
hypoglycemia.    
Hypotheses 2.2: Neonates with hypoglycemia will consume a higher percentage of 
resources associated with hospital births while accounting for a smaller percentage of 
hospitalization.  
Aim 3: To construct multilevel models for individual and contextual predictors of neonatal 





Hypotheses 3.1: Infants born from diabetic mothers have significantly higher chance of 
developing hypoglycemia compared to those born from non-diabetic mothers. 
Hypotheses 3.2: The addition of the contextual risk factors will enhance the predictive 
power of the model that will be constructed to predict neonatal hypoglycemia in diabetic 
and non-diabetic pregnancies.    
Operational Definitions 
 
Comorbidities: ICD-9-CM codes indicating any of the following medical conditions; jitteriness 
(796.9), hypotonia (781.3), lethargy (799.22), apnea (786.03), tachypnea (786.06), poor feeding 
(783.3), hypothermia (991.6), sepsis (995.91& 771.81), seizures (345.x), and 
neurodevelopmental disorder (315.x). 75, 76 
Contextual-Level Characteristics: Contextual risk factors such as neighborhood socio-economic 
status, hospital characteristics, seasons, and regions. 
Cost-to-Charge Ratios (CCRs): CCRs enables the conversion of actual cost from total hospital 
charge (i.e. Hospital Costs = Cost-to-Charge Ratios*Total Charges).77, 78 
Diagnosis Related Groups, version 24 (DRG24): A statistical system of classifying any inpatient 
stay into one of originally 467 groups. DRG24 is assigned by the Centers for Medicare and 
Medicaid Services DRG grouper algorithm during HCUP processing and has been available 
since 2006.54 
Exosystem: Comprises the linkages and processes taking place in two or more settings, at least 
one of which does not contain the developing person, but in which events occur that indirectly 
influence processes within the immediate setting in which the developing person lives.58, 59 
Hospital File: It contains variance estimation data elements, linkage data elements, and data 





Hypoglycemia: A metabolic abnormality in neonates due to inability to maintain glucose 
homeostasis.1,2 
In-hospital Births: They are identified by any principal or secondary diagnosis code in the range 
of V3000 to V3901 with the last two digits “00” to “01” whereby the patient is not transferred 
from another acute care hospital or healthcare facility.54 
Individual-level characteristics: Demographics, clinical, and laboratory measures of the mother 
and the child.  
Kids’ Inpatient Database (KID): KID is a database developed by the Healthcare Cost and 
Utilization Project (HCUP) of the Agency for Healthcare Research and Quality (AHRQ) which 
contains a sample of pediatric discharges from all community, non-rehabilitation hospitals in 44 
participating States.54 
Macrosystem: It indicates policy and societal culture that ultimately affect the particular 
conditions and process occurring in the development of a child.58,59 
Major Diagnostic Categories (MDC): Obtained by classifying all possible principal diagnoses 
(from ICD-9-CM) into 25 mutually exclusive diagnosis areas.54 
Maternal Diabetes: Diagnosis information (DX1-DX25) or Major Diagnosis Category (MDC) 
are coded as ‘250.00’ to ‘250.93’ and the variable neonatal/maternal flag (NEOMAT) indicates a 
maternal diagnosis (codes as ‘1’ or ‘3’).75,76 
Mesosystem: Comprises the linkage and process taking place between two or more settings such 
as the relationship between a mother and her child.58,59 
Microsystem: Indicates the immediate environment that proximal processes operate to produce 





Neonatal hypoglycemia (NH): If any of the diagnosis information (DX1-DX25) variables is 
equal to ‘775.6’, the newborn infant is identified as having experienced neonatal hypoglycemia 
during his or her hospital stay.75,76 
The International Classification of Diseases, 9th version (ICD-9-CM): ICD-9-CM is the United 
States health system's adaptation of international ICD-9 standard list of six-character 
alphanumeric codes to describe diagnoses.76 
Assumptions 
 
The primary assumptions of this dissertation were the following: 
For Chapter III and IV: 
1. Kids’ Inpatient Database developed by the Healthcare Cost and Utilization Project of 
the Agency for Healthcare Research and Quality is accurate and valid. 
2. The definition of neonatal hypoglycemia is universally accepted by the medical 
community.  
3. All symptomatic and asymptomatic neonatal hypoglycemia were included in the 
database. 
4. The International Classification of Diseases, 9th version, is an accurate coding 
mechanism to identify diagnosis and procedures associated with neonatal 
hypoglycemia.  
5. The social ecological model assumes that multiple factors influence health.63,64 
6. There is a reciprocal relationship between individuals and their environments.63,64 
7. Human-environment interactions can be described at varying levels of organization.64 
8. All hospital participated in the Healthcare Cost and Utilization Project has proper data 





For Chapter IV: 
1. Assumptions 1-8 for Chapter III and IV 
2. Individual level and contextual level characteristics encompass all potential risk factors 
for the development of neonatal hypoglycemia. 
Delimitations 
 
1. Subjects are male and female neonates discharged from community, non-rehabilitation 
hospitals in the United States.  
2. The study will be limited to uncomplicated and complicated in-hospital births and will 
not include all other pediatric cases. 




For Chapter III and IV:   
1. Inconsistencies in the collection of data and quality problems may hinder the use of 
hospital discharge data for specific applications such as comparative analysis.79,80 
2. Errors in providers’ understanding of diagnostic coding/groupings (e.g., ICD-9-CM, 
DRG, MDC) may lead to misclassification.81  
3. Co-morbidities (reported as secondary diagnosis codes) may be underreported, 
particularly for some conditions that are not directly associated with cause of 
admission.82,83 
4. Only 44 states participate in the in Healthcare Cost and Utilization Project. Even in those 





Administration and Indian Health System facilities, are typically exempt. Incomplete data 
can hinder efforts to use discharge data at the State and national level.81 
5. Submission of discharge data is voluntary in some states and submission of certain data 
elements may be voluntary even in states that mandate hospital participation resulting in 


























REVIEW OF THE LITERATURE 
 
The purpose of this chapter is to systematically review the literature regarding whether 
previous studies only focused on clinical risk factors or included broader contextual risk factors 
in assessing the determinants of neonatal hypoglycemia. Chapter II (Project I), Neonatal 
hypoglycemia in diabetic mothers: a systematic review, critically appraises the literature to 
evaluate risk factors of neonatal hypoglycemia. PubMed and EBSCOhost search engines were 
used to identify published studies. A modified STROBE statement was also used to assess 
studies’ strengths, weaknesses, and generalizability. Overall, this chapter provides a synthesis of 
the literature regarding the relationship between hypoglycemia and diabetic pregnancies. The 
overall evidence suggested that the studies included in the systematic review mainly focused on 
clinical risk factors. The reviewed risk factors were classified into two: infant-related and 













   
 
 




Neonatal hypoglycemia is a common metabolic abnormality in newborns due to inability 
to maintain glucose homeostasis.84,85 Glucose is an essential primary substrate for the brain and 
its consumption by the brain is high and as a result, neurons and glial cells are susceptible to 
hypoglycemia.86,4 Therefore, glucose homeostasis is crucial for the overall physical and 
neurological development of newborns.6 Throughout gestation, maternal glucose provides all the 
glucose for the fetus via facilitated diffusion across the placenta according to a maternal-to-fetal 
glucose concentration gradient.6 Hypoglycemia was defined by studies as early as 1937 as 
“mild” (2.2–3.3 mmol/l), “moderate” (1.1–2.2 mmol/l), and “severe” (<1.1 mmol/l).7 A specific 
blood glucose concentration to define neonatal hypoglycemia for infants is a subject of 
controversy.8,11, 87 However, it is generally accepted that neonatal hypoglycemia is defined by a 
plasma glucose level of less than 30 mg/dl or 1.65 mmol/l in the first 24 hours of life.12 To date, 
hypoglycemia remains one of the major metabolic abnormalities of the newborn.13,15, 88 
The most common symptoms of neonatal hypoglycemia are shakiness, tachycardia, 
lethargy, and temperature irregularities.23, 39 In the presence of these symptoms, neonatal 
hypoglycemia is defined as capillary plasma glucose of less than 46 mg/dl (2.6 mmol/l).23 
Prolonged neonatal hypoglycemia may also cause neuroglycopenic signs such as seizure, coma, 
cyanotic episodes, apnea, bradycardia or respiratory distress, and hypothermia.4, 22 
Several clinical conditions could be associated with neonatal stress that could affect 
glucose homeostasis of the newborn infant including infection, asphyxia, congenital heart 
disease, decreased substrate availability as a result of birth defects, prematurity and fetal growth 
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restriction, islet cell hyperplasia, erythroblastosis fetalis, and Beckwith-Wiedemann 
Syndrome.4,15, 17-21 In addition, endocrine abnormalities such as pan-hypopituitarism, 
hypothyroidism, adrenal insufficiency, increased glucose utilization, sepsis, and perinatal 
asphyxia could also be associated with neonatal hypoglycemia.17,18 Although in most of these 
neonates, hypoglycemia is transient and asymptomatic, unrecognized hypoglycemia may lead to 
neonatal seizures, coma, and neurologic injury.23, 41 
The risk of developing hypoglycemia among infants born from diabetic mothers is even 
higher.25-35 Hypoglycemia occurs in approximately 8-30% of neonates born to mothers with 
diabetes33,34, with an estimated incidence rate of approximately 27% among infants born to 
women with diabetes compared to 3% among apparently healthy full-term infants born to 
nondiabetic women.35, 36 Although the predisposing risk factors for the development of neonatal 
hypoglycemia in diabetic pregnancies are thought to be mainly related to poor maternal glycemic 
control, neonatal weight at birth, and gestational age at delivery37,38, the full extent of the 
individual and contextual risk factors remains unclear. In addition, to date, no systematic reviews 
of the available studies exist.  
Our objective is to conduct a systematic review of the literature on the risk factors for 
hypoglycemia in infants of diabetic mothers. Accordingly, all relevant empirical studies on 
neonatal hypoglycemia in diabetic mothers were reviewed and appraised for methodological 








   
 
 
We identified published studies using PubMed and EBSCOhost search engines. The 
search was carried out by using the population, intervention, control, and outcome (PICO) 
strategy. The following concepts and related key words searched in their respective PICO 
category and they were finally combined together: (1) neonatal terms (‘neonate, ‘neonates’, 
‘neonatal’, ‘newborn’, ‘newborns’, and ‘infant’), (2) diabetes and pregnancies terms (‘pregnancy 
in diabetics’, ‘diabetic mothers’, ‘diabetic pregnancy’, ‘pregnancy in diabetes’), and outcome 
terms (‘hypoglycemia’, ‘hypoglycaemia’, ‘hypoglycemic’, and ‘neonatal hypoglycemia’). We 
included all empirical studies published in the English language between January 1, 2000, and 
March 31, 2016. Additional studies were identified from reference lists of identified articles. The 
following inclusion and exclusion criteria were used to identify relevant articles: 
Inclusion criteria: (1) observational studies, (2) neonatal hypoglycemia is used as the 
primary outcome of interest, (3) neonates born from type 1 (defined as blood glucose ≥11.1 
mmol\l), type 2 (defined as fasting blood glucose ≥ 7.0 mmol\l or ≥11.1 mmol\l during OGTT) 
or gestational diabetic mothers (defined as having at least two plasma glucose measurements 
during the diagnostic test of the following OGTT glucose threshold values: 5.3 mmol/l fasting, 
10.0 mmol/l at 1 hr, 8.7 mmol/l at 2 hr, and 7.8 mmol\l at 3 hr ), (4) has appropriate comparison 
group, (5) neonatal hypoglycemia diagnosed within 3 days of life, and outcome defined in the 
ranges of 20 to 50 mg/dl or 1.1-2.8 mmol/l. 
Exclusion Criteria: (1) animal studies, (2) review articles, (3) articles published in a non-
English language, (4) articles published prior to 2000, and (5) poorly defined or no comparison 
group. 




   
 
 
The abstracts of all potential publications were reviewed initially by the first (B.A.) and 
the second (O.O.) authors to identify eligible publications for further review. Full text screening 
was made by the two authors through a detailed review of the complete text of each articles 
using the inclusion/exclusion criteria as a guideline. The two authors then independently 
reviewed publications that were identified for inclusion. Relevant study attributes were extracted 
from the selected publications using standardized forms developed for the systematic review 
project by the authors. A third author (M.A) mediated to resolve any disagreements between the 
authors.    
The STROBE (Strengthening the Reports of Observational Studies in Epidemiology) 
Statement (checklist of items that should be included in reports of observational studies) was 
used to assess studies’ strengths, weaknesses, and generalizability. An explanation and 
elaboration article that discusses each checklist item and gives methodological background and 
published examples of transparent reporting were used in conjunction with the STROBE 
checklist.41 As most of the studies on this topic are observational, we used the STROBE checklist 
as a guide to systematically evaluate the studies that were included in this review. The STROBE 
checklist has 21 items with 15 items relevant to all three study designs (i.e. cohort, case-control, 
and cross-sectional studies) and 4 are specific for each. However, items 1-3 (background and 
objectives), 6b (for matched studies), 11(quantitative variables), and 22 (funding information) 
were removed as they were not applicable to the included studies. Therefore, a modified 15-item 







   
 
 
 A total of 1233 titles were identified on PubMed and EBSCOhost in the initial literature 
search, 1202 of which were excluded by the first screening based on the title or abstract, leaving 
31 articles for full-text review (Figure II.1). Thirteen of these studies met the inclusion criteria 
and an additional 3 articles were included from reference lists25,33,34, resulting in 16 eligible 
studies, most of which were based on observational studies (Table II.1). The main reasons for 
excluding studies after full review were (i) hypoglycemia was not listed as primary outcome, (ii) 
comparison group were not defined and, (iii) hypoglycemia was not defined within the specified 
range of 1.7-2.8 mmol/l. 
 We identified four prospective cohorts, one nested case-control and ten retrospective 
cohort studies that examined the various clinical risk factors for hypoglycemia in diabetic 
mothers. Mother’s diabetes types included gestational diabetes mellitus (GDM), type-1 diabetes 
mellitus (T1D), and type-2 diabetes mellitus (T2D). Other details on included studies are 
summarized in Table II.1. A total of 13,248 infants were identified in the 16 included studies. 
The key findings are described in the following section. 
Critical Appraisal 
 
The two authors agreed initially on 228 out of 240 (95%) items on the modified STROBE 
checklist. All disagreements were resolved by discussion among the two reviewers. Overall, the 
quality scores of the included studies ranged from 26.7% to 86.7%, with a median of 46.7%. 
Included studies were classified as high quality if the individual quality scores were ≥80%, 
studies were classified as moderate quality for quality scores between 79% and 60% and studies 
with quality scores below 59% were classified as low quality. Accordingly, a total of five high 
quality15,39,26-28, two moderate quality29,30, and nine low quality studies were identified.12,21,31,32,33-
38 The individual item, assessment responses, and quality scores can be found in Table II.3. 
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Clinical Significance and Risk Factors of Neonatal Hypoglycemia  
 
 Four prospective cohort studies21,25,91,92 examined various risk factors of hypoglycemia in 
neonates of women with different diabetes type. Roux et al.25 prospectively examined glucose 
levels in infants of women with GDM and the influence of maternal, gestational and peripartum 
factors on the development of hypoglycemia. They found that hypoglycemic infants were more 
frequently large for gestational age (LGA) (29.3% vs 11.3%), had lower umbilical cord pH (7.28 
vs 7.31), and their mothers had more frequently been hyperglycemic during labor (18.8% vs 
8.5%). The study obtained data from infants born in a hospital to mothers with GDM over a 
period of 30 months. After adjusting for confounding factors, umbilical cord venous pH [odds 
ratio (OR) 0.04, 95% Confidence Interval (CI) 0.261–0.99)] and Pakistani origin patients (OR 
2.94, 95% CI 1.14 7.55) were significantly and independently associated with hypoglycemia. 
Similarly, Agrawal et al.21 found that infants of mothers diagnosed with GDM or preexisting 
diabetes prior to 28 weeks gestation were at a higher risk of developing hypoglycemia compared 
to those with maternal diabetes diagnosed at 28 weeks gestation (OR 7.2, 95% CI 1.3-40.7). 
However, there was no difference in the cord blood glucose levels between infants with or 
without hypoglycemia.  
 Sarkar et al.91, on the other hand, examined the risk of developing hypoglycemia in 
infants born to women with diet-controlled GDM (GDM-A1), insulin-requiring (GDM-A2) and 
insulin-dependent diabetes (IDDM) at ≥ 36 weeks of gestation compared to infants born to 
healthy controls using data obtained over a period of 16 months. They found that there is no 
significant difference in the incidence of hypoglycemia in infants born to GDM-A1 (4.3%) 
compared to infants born to healthy controls (4.4%). They concluded that infants born to GDM 
Class A1 women at ≥ 36 weeks of gestation are not at increased risk of developing 
24 
  
   
 
 
hypoglycemia. On the other hand, Cordero and Landon35,36 found a 3% incidence of transient 
hypoglycemia in healthy full-term infants born to nondiabetic women.  
 Using national data from the Swedish Medical Birth Registry, Persson et al.92, 
investigated whether disproportionate body composition is a risk factor for perinatal 
complications, including hypoglycemia, in LGA infants born to mothers with T1D. Their 
findings showed that there was no significant difference in the risk for hypoglycemia between 
proportionate LGA (OR 1.42, 95% CI 1.01-2.0) and disproportionate LGA infants (OR 1.42, 
95% CI 0.97-2.08) compared to appropriate for gestational age (AGA). Disproportionate LGA 
was defined as Ponderal Index (PI) >90th centile and proportionate <90th centile LGA according 
to gestational age and sex. Similar results were obtained by Leperque et al.93 while Ballard et 
al.94 and Bollepalli et al.95 contrasted the result. Furthermore, Ferrara et al.96 found that women 
with GDM defined by American Diabetes Association (ADA) criteria had an increased risk of 
having an infant with hypoglycemia (OR 2.61, 95% CI 0.99–6.92), although not statistically 
significant. The study used a group practice database that included 16 hospitals and provides 
medical services to approximately 3.0 million people. Their findings supported the ADA 2000 
recommendations (GDM, 2000) to adopt a lower plasma glucose thresholds proposed by 
Carpenter and Coustan97 for the diagnosis of GDM. 
 We also identified ten retrospective cohort studies and one nested case-control 
study23,33,34,72,70,95,98-101 that examined the risk of developing hypoglycemia in infants born to 
mothers with different diabetic conditions. Most of these observational studies were conducted 
using single institution databases.  
 Garcia-Patterson et al.72 examined the relationship between maternal pre-pregnancy BMI 
and hypoglycemia among infants born to women with GDM with a gestational age higher than 
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22 weeks using databases from a tertiary care center. Maternal pre-pregnancy BMI ≥25 kg/m2 
was determined as an independent predictor of hypoglycemia irrespective of potential 
intermediate variables being included in the model (OR 2.11, 95% CI 1.10–4.03) or without (OR 
2.66, 95% CI 1.44–4.92). The rate of hypoglycemia in neonates was 3% (63). On the other hand, 
Maayan-Metzger et al.33 examined the impact of duration of delivery room breastfeeding on 
blood glucose levels (BGL) during the first hours of life among term neonates born to mothers 
with GDM and to examine its relationship with hypoglycemia using a medical center database. 
Among the neonates in the study group, 29 (36.7%) had at least one hypoglycemia value of <47 
mg/dl, and 8 (10.1%) had a value of <40 mg/dl in the first 8 hours of life. After controlling 
confounding factors such as birth weight, delivery number, and grasp evaluation, only lower cord 
blood glucose significantly predicted hypoglycemia for each decrease of 10 mg/dl (OR 2.11, 
95% CI 1.1–4.03). The mean glucose at the first hour of life was 56.2 mg/dl (range 28–105 
mg/dl). A trend towards a higher incidence of normoglycaemia (>40 mg/dl) was recorded for the 
longer duration of delivery room breastfeeding subgroup (OR 1.923, 95% CI 0.984-3.76). 
However, the duration of delivery room breastfeeding did not influence the rate of 
hypoglycemia. In contrast to this findings, Chertok et al.102 found that breastfed infants had a 
significantly higher mean BGL (3.20 mmol/l) compared to those who were formula fed (2.68 
mmol/l). One reason for the different results could arise from the definition of hypoglycemia. In 
Garcia-Patterson, et al.72 hypoglycemia was defined as “normal” (≥2.6 mmol/l), “mild 
hypoglycemia” (2.2–2.5 mmol/l), “moderate hypoglycemia” (1.7–2.1 mmol/l) and “severe 
hypoglycemia” (1.7 mmol/l). While Chertok et al.102 defined hypoglycemia as BGL < 1.93 
mmol/l and borderline hypoglycemia were 1.93–2.48 mmol/l. In addition to differences in 
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measurement, the difference in adjusting factors may have contributed to the apparent contrast in 
the results.     
 Ramos et al.23 assessed factors associated with hypoglycemia in a cohort of pregnancies 
with T2D and GDM. The incidence of hypoglycemia in this study was 18% (44/242). The 
frequency of hypoglycemia between the glyburide and insulin-treated pregnancies did not differ 
significantly (23% vs. 27%). Maternal age ≥35 years (OR 2.78, 95% CI 1.13–6.85) and Ponderal 
Index (OR 5.59, 95% CI 1.34–23.25), a measure of fetal adiposity, significantly predicted 
hypoglycemia. Similarly, Majeed et al.73 investigated if maternal glycated hemoglobin (HbA1c) 
was a good predictor of hypoglycemia. As hypothesized HbA1c in late pregnancy, between 36 
and 38 weeks of gestation, significantly predicted hypoglycemia in the newborn, giving an area 
under the ROC curve of 0.99 with a 95% CI of 0.992 to 1. A ROC curve determined the optimal 
cut-off point for maternal HbA1c level in predicting hypoglycemia, was 51 mmol/l (6.8 %). 
However, various studies gave mixed results regarding the association between maternal HbA1c 
and hypoglycemia. Using logistic regression Kline & Edwards 2007 also found that a third 
trimester HbA1c of > 6.5% (47.54mmol/l) had a stronger association with neonatal 
hypoglycemia requiring intervention when compared to maternal delivery BGLs (OR 3.89, 95% 
CI 1.42-10.68). However, Taylor, et al.100 found that hypoglycemia correlates with maternal 
hyperglycemia in labor, not with HbA1c during pregnancy. They found that maternal blood 
glucose during labor influenced neonatal blood glucose if over 8 mmol/l.  
Discussion  
 
 Neonatal hypoglycemia is the most common metabolic abnormality in newborn infants 
due to the inability to maintain glucose homeostasis13,84 To date, the full extent of various risk 
factors of hypoglycemia in infants of diabetic mothers are not known. Our findings are the result 
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of a systematic search for all relevant studies on hypoglycemia in diabetic mothers and critical 
appraisal of methodologies and study quality assessment.  
We found few prospective studies that carefully examined the clinical and demographic 
risk factors of hypoglycemia among neonates. However, the majority of studies identified in our 
literature review were observational retrospective design that used existing institutional 
databases. As a result, after assessing studies’ strengths, weaknesses, and generalizability using 
the STROBE Statement103, the overall quality of evidence was low. The clinical risk factors in 
these studies can be broadly classified into two: infant-related and mother-related clinical risk 
factors. The infant-related significant risk factors identified in these study were SGA, 
LGA43,70,95, macrosomia, prematurity94, lower cord blood glucose33, Ponderal Index23, and male 
sex101. On the other hand, mother-related significant risk factor of hypoglycemia includes 
maternal hyperglycemia, ethnic origin25, diabetes diagnosed prior to 28 weeks of gestation21, pre-
pregnancy BMI ≥25 kg/m272, hyperglycemia, blood glucos100, maternal diabetes type94, and 
material HbA1c.73 Although several other risk factors were considered in these studies, the 
statistically significant risk factors are important for understanding the clinical management of 
the study population and future studies using multilevel design of risk assessment. Irrespective of 
diabetes type, it appears that infants of diabetic mothers have a higher risk of hypoglycemia 
compared to those born to normal mothers.91, 96 
Overall, the results of the individual studies assessed various risk factors. However, a 
consistent pattern of risks of hypoglycemia among infants of diabetic mothers was not identified 
which may be the result of several factors. First, as the definition of clinical significance of 
hypoglycemia remains one of the contentious issues in contemporary neonatology6,8,10,37,106-109, 
individual studies included in this review used different definitions of hypoglycemia ranging 
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from <1.1 mmol/l to <2.8mmol/l. The variation in the definition of hypoglycemia has an 
important implication on the predictive power of individual studies. The standard of care in most 
neonatology units involves close surveillance if the plasma glucose concentration is less than 2.2 
mmol/l.40,73,110-116 Second, mothers included in this review were diagnosed with diabetes. 
However, there was variation in the type of diabetes. The review included mothers with T1D, 
T2D, GDM, which are commonly recognized.37, 106 Sarkar et al.91 pointed out that the incidence 
of hypoglycemia and the associated risk factors may vary based on the specific type of diabetes. 
Third, about 65% of studies identified in the review were observational studies that used existing 
data collected as part of the standard of care (i.e. not for research purpose). In this regard, 
collecting prospective data or using national registry data may have provided more consistent 
predictors of hypoglycemia. Fourth, individual studies used different measurements of blood 
glucose. Although more than 76% of studies specified their blood glucose measurement 
methods, variations in these methods, measurement time, and place (laboratory vs. bedside) may 
have affected the accuracy of blood glucose measurement. Similarly, a recent systematic review 
identified 18 studies that examined neonatal hypoglycemia and its relationship to 
neurodevelopmental outcomes found a higher rate of heterogeneity among studies.43 In our 
study, we also found major clinical heterogeneity in patient characteristics, measurement of 
hypoglycemia, design, and quality. As a result, statistical pooling of result to conduct a meta-
analysis was not carried out.  
Overall, the majority of the studies in our review were observational in design, which 
makes an inference of causality difficult, especially when different protocols were followed to 
measure, handle, and analyze blood sampling. Less than a third of the studies used a prospective 
design to minimize errors associated with measuring exposure. Key limitations include the 
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possibility of publication bias. As our review found both positive and negative results, 
publication bias may not be a great concern for the current review. The fact that our systematic 
review included studies only written in English may be another limitation. However, previous 
studies have shown that language restrictions in systematic reviews have minimal effect on the 
results.117,118  The fact that 47 percent of studies did not report a laboratory measurement for 
confirmation of neonatal hypoglycemia and the lack of generally acceptable definition of 
neonatal hypoglycemia may have affected the proper direction of the outcome. However, as all 
studies followed a written clinical protocol in the management of hypoglycemia, the bias 
associated with laboratory confirmation is not differential.   
Conclusions and Recommendations for Future Research 
 
In summary, there is evidence supporting the clinical importance of giving attention to 
infants of diabetic mothers. Irrespective of the type of diabetes, infants of diabetic mothers have 
a higher risk of developing hypoglycemia compared to those born to mothers without diabetes. 
However, the studies included in this review mainly focused on the clinical characteristics of the 
infants and mothers. Future research should also focus on identifying other factors that may 
increase the risk of neonatal hypoglycemia such as neighborhood and institutional characteristics 
including, genetics, socioeconomic status, and disparities in health care delivery. This can be 
accomplished by taking the following four steps: 
1.  Defining neonatal hypoglycemia using the multiple clinical cut-of-points to identify 
the most salient risk factors.  
2. Using large population based national registry database that is developed to facilitate 
the conduct of analyses pertaining to neonatal complications will help to obtain 
adequate comparison groups.  
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3. Stratifying the mother’s diabetes type to identify the significance of T1D, T2D, and 
GDM on the risk of developing neonatal hypoglycemia.  
4. Using multilevel statistical models to incorporate the individual and contextual 
characteristics of infants and mothers.
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Table II.1.Continued.  
 
 
UCBG, umbilical cord blood glucose; RDS, respiratory distress syndrome; BW, birthweight; NS, not stated; HbA1c, glycated hemoglobin; HB; hyperbilirubinemia; 
AC, acidosis; PC, polycythemia; MS, macrosomia; GA, gestationalage; IT, insulin treatment; BMI, body max index; WDP; weight during pregnancy; MP, multiple 
pregnancy; NG, newborn gender, BI, birth injury; CH; cephalhaematoma, HS, hospital stay; CD, Cephalhaematoma; CD, Cesarean Delivery; MA, Maternal Age; 
MH, Maternal Hypertension; MSAF, meconium-stained amniotic fluid; AS, apgar score; PE, pre-eclampsia; BT, birth trauma; ARD, acute respiratory disorders; 
PI, ponderal index, MOGCT, maternal oral glucose challenge test; PBMI; Pregestational BMI; IG, insulin in gestation, IL, insulin in labor; UCPH; umbilical cord 
venous pH; MBG, maternal blood glucose, MC, microsomia; PT, polycythemia; HC, hypocalcaemia; PM, perinatal mortality; CM, congenital malformation; OT, 
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Table II.2. Results of Included Studies of Hypoglycemic Neonates Born from Diabetic Mothers 
Author (s) Years Main Results 
Agrawal, et al., 2000 Hypoglycemia in 18 (47%) infants developed during the first 2 h of life. There was no difference in the cord blood glucose 
levels between infants with or without hypoglycemia. Infants of mothers with diabetes diagnosed prior to 28 weeks 
gestation were at a higher risk of developing hypoglycemia (OR: 7.2, 95% CI: 1.3–40.7). Hypoglycemic infants were of 
significantly higher birthweight (3681) compared to normal infants (3160).  
 
Majeed et al., 2011 There were 16 neonates who were hypoglycemic at delivery. The area under the Receiver Operator Characteristics (ROC) 
curve for predicting neonatal hypoglycemia was 0.997 with a 95% CI of 0.992 to 1. The optimal threshold value for HbA1c 
in predicting NH was 6.8%. 
 
Bollepalli, et al., 2010 Asymmetric LGA infants had 3.5 (95% CI: 1.4, 8.7), 2.2 (95% CI: 1.2, 4.2), and 3.2 (95% CI, 1.7, 5.9) fold greater odds of 
hypoglycemia, hyperbilirubinemia, and composite morbidity, respectively, compared with symmetric non-LGA infants. 
 
Ferrara, et al., 2007 A total of 486 with infants with hypoglycemia, 488 with macrosomia, and with hyperbilirubinaemia were identified. 
Women with GDM by ADA criteria had an increased risk of having an infant with hypoglycemia (OR: 2.61, 95% CI: 0.99–
6.92), macrosomia (OR: 3.40, 95% CI: 1.55–7.43), or hyperbilirubinaemia (OR: 2.22, 95% CI: 0.98–5.04) compared to 
healthy control infants. 
 
García-Patterson, et al., 2012 The rate of hypoglycaemia in neonates was 3% (63). Maternal pre-pregnancy BMI of ≥25 kg/m2 was an independent 
predictor of hypoglycaemia irrespective of potential intermediate variables being included in the model (OR: 2.11, 95% CI: 
1.10–4.03) or without (OR: 2.66, 95% CI:1.44–4.92).  
 
Das et al., 2009 The incidence of hypoglycemia among IDMs was 56.1% compared to non-IDMs 28.6%. There was significantly more 
hypoglycemia among the group weighing >4500 g compared to the group weighing 4000–4499g. Compared to IDMs, non-
IDMs were born later (40 vs 38 wk), were more likely to be delivered vaginally (70% vs 34%), and had a higher incidence 
of birth injury than IDMs (8% vs 2.4%).  
 
Maayan-Metzger et al., 2014 
 
Among the neonates in the study group, 29 (36.7%) had at least one hypoglycemia value of <47 mg/dl, and 8 (10.1%) had a 
value of <40 mg/dl in the first 8 hours of life. After controlling confounding factors such as birth weight, delivery number, 
and grasp evaluation only lower cord blood glucose significantly predicted hypoglycemia for each decrease of 10 mg/dl 
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Author (s) Years Main Results 
Mitroviu et al., 2014 The incidence of neonatal hypoglycemia was 52% in mothers with Type 1 diabetes and 16.5% in mothers with Type 2 
diabetes or GDM. The incidence neonatal morbidities such as hypoglycemia, pathological jaundice, and other neonatal 
pathologies at birth, was statistically significantly higher and Apgar scores after 1 minute and after 5 minutes were 
statistically significantly lower in the mothers with diabetes (type 1 & 2) compared to the healthy women. 
 
Persson et al., 2012 Neonatal morbidities were significantly more frequent in LGA compared to AGA infants. The proportions of preterm 
births and girls were significantly higher in LGA infants (44% preterm and 52% girls) compared with AGA infants 
(30% preterm and 47% girls) born to women with Type 1 diabetes. The risks of hypoglycemia were comparable between 
P-LGA and D-LGA infants. No significant difference in risk was found between AGA and P-LGA and D-LAG. 
 
Ramos et al., 2010 The incidence of hypoglycaemia was 18% (44/242). The incidence was significantly higher in those requiring 
pharmacotherapy (25% vs. 3%). The frequency of hypoglycaemia between the glyburide and insulin-treated pregnancies 
did not differ significantly (23% vs. 27%). The frequency of hypoglycaemia was statistically associated with birth 
weight, macrosomia, and ponderal index. Ponderal index was the strongest predictor of hypoglycaemia (OR: 5.59, 95% 
CI: 1.34–23.25). 
 
Flores-le Roux et al., 
2012 
A total of 23 (12.1%) mild, 20 (10.5%) moderate and 5 (2.6%) severe hypoglycemia were observed. Hypoglycemic 
infants were more frequently LGA (29.3% vs 11.3%), had lower umbilical cord pH (7.28 vs 7.31) and their mothers had 
more frequently been hyperglycemic during labor (18.8% vs 8.5%). Pakistani origin (OR: 2.94; 95% CI: 1.14 7.55) and 
umbilical cord venous pH (OR: 0.04, 95% CI: 0.261–0.99) were significantly and independently associated with 
hypoglycemia in multivariate analysis. 
 
Ryan et al., 2012 The NH rate was 7.3% (4.9% in GDM mothers and 10.9% of mothers with pre-existing diabetes). The insulin-glucose 
infusion was used in 47% of women with T1D, T2D, and GDM requiring ≥ 0.5 units/kg/day of insulin during pregnancy 
and in 8% of women with GDM treated by diet or < 0.5 units/kg/day of insulin. The overall rate of maternal 
hypoglycaemia was low (6.6% with blood glucose ≤ 3.5 mmol/L and 1.5% ≤ 3.0 mmol/L) pre-delivery; 13.9% of 
women had a blood glucose level ≥ 7.0 mmol/L. Standardized management for diabetic women in labour using an 










Table II.2. Continued.  
 
Authors (s) Years Main Results 
Sarkar et al., 2003 The incidence of hypoglycemia was 4.3% in the GMD-A1 group compared to the control, 4.4%. Neonatal morbidity in 
infants born to GDM-A1 women is similar to that seen in infants of nondiabetic women. Unlike infants of insulin-
dependent diabetic and insulin requiring GDM women, infants born to GDM-A1 women at 36 weeks of gestation or more 
were not at increased risk of developing hypoglycemia, hypocalcemia, hypomagnesemia, polycythemia, 
hyperbilirubinemia, birth trauma, or birth asphyxia. Infants born at 36 weeks or more gestation to class A1 GDM women 
can be managed like any other normal full-term infant born to a nondiabetic woman.  
 
Taylor, et al., 2002 Hypoglycemia correlates with maternal hyperglycemia in labor, not with HbA1c during pregnancy. Blood glucose was 
less than 2.5 mmol/l in 50 neonates and was less than 2.0 mmol/l in 18 neonates. Maternal blood glucose control in 
pregnancy had no bearing on the incidence of NH, but maternal blood glucose during labor influenced neonatal blood 
glucose if over 8 mmol/l.  
 
Tundidor, et al., 2012 Male sex was an independent predictor of neonatal hypoglycemia (OR: 2.13) and CS (OR: 1.48). As to neonatal 
hypoglycaemia, intravenous glucose was required in 16.7% of infants (7.4% in female vs 24.2% in male fetuses; NS). The 
increased risk of neonatal hypoglycemia in male fetuses of mothers with GDM is also the most relevant result in terms of 
clinical practice, advising an increased awareness of neonatal hypoglycemia in these newborns. 
 
VanHaltren et al., 2013 Hypoglycaemic episodes occurred in 109 (33.4%) infants. Macrosomia was present in 15% of the infants. Maternal 
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1233 Studies retrieved in the initial search  
 661 EBSCOhost 
 572 PubMed 
 
 1233 Titles and abstracts read   
31 Full articles were reviewed  
A total of 16 articles met the inclusion criteria and were included for detailed review   
 Animal studies  
 Review articles  
 Written in the non-English language  
 Studies not conducted between 2000 and 2016 
 Duplicates   
 
 7 Studies did not include diabetic mothers  
 4 Hypoglycemia not listed as primary outcome 
 4 Comparison group not defined 
 3 Hypoglycemia not defined in mmol/l or mg/dl 
  





PROJECT II: PREDICTORS OF HOSPITALIZATION COST IN INFANTS WITH 




Neonatal hypoglycemia is a common metabolic abnormality in newborns due to inability 
to maintain glucose homeostasis.4,84 Throughout gestation, mothers provide all the glucose for 
their fetuses via facilitated diffusion across the placenta according to a maternal-to-fetal glucose 
concentration gradient.6 The disruption of this process can lead to several acute and chronic 
illnesses. The most common symptoms of neonatal hypoglycemia are shakiness, tachycardia, 
lethargy, and temperature irregularities.23 In the presence of these symptoms, neonatal 
hypoglycemia is defined as capillary plasma glucose of less than 46 mg/dl (2.6 mmol/l).8,23 
Several clinical conditions could be associated with neonatal hypoglycemia that could affect 
glucose homeostasis including asphyxia, congenital heart disease, decreased substrate 
availability as a result of birth defects, prematurity and fetal growth restriction, islet cell 
hyperplasia, and Beckwith-Wiedemann Syndrome.15,17,18,20,21 Prolonged neonatal hypoglycemia 
may also cause neuroglycopenic signs such as seizures, coma, cyanotic episodes, apnea, 
respiratory distress, and hypothermia.4 
Previous studies on this topic mainly focused on the clinical risk factors and analyses aimed 
at improving the management and care of neonatal hypoglycemia. However, the economic 
burden and overall hospital cost estimates has not been studied at the national level in the United 
States (US). Although not in neonates, the economic burden of hypoglycemia has been 
adequately addressed in adult populations44-49. This study sought to determine the overall 








This is a retrospective study based on the 2012 Kids’ Inpatient Database (KID) developed by 
the Healthcare Cost and Utilization Project (HCUP) of the Agency for Healthcare Research and 
Quality (AHRQ).54 The KID is the largest publicly available all-payer pediatric (≤20 years of 
age) inpatient care database in the United States. The database is a sample of pediatric discharges 
from all community, non-rehabilitation hospitals in 44 participating States. Systematic random 
sampling is used to select 10% of uncomplicated in-hospital births and 80% of other pediatric 
cases from each participating state. The 2012 KID database includes 4179 hospitals with 
3,195,782 pediatric discharges. HCUP categorize hospital regions as northeast, mideast, south, 
and west. Hospital ownership, teaching status, location, bed size, and other important hospital 
characteristics were also included in the database.  In total, 70 children’s hospitals (400,835 
pediatric discharges) and 4,109 hospitals that admit all patients (2,794,947 pediatric discharges) 
were included in the 2012 database. As we are interested only in neonates, this analysis is limited 
to uncomplicated and complicated in-hospital births. 
For the purpose of our analysis the inpatient core file, the hospital file, and cost-to-charge 
ratios file of the KID 2012 database were used. Neonates with hypoglycemia (775.6) were 
identified using the 9th version of the international classifications of diseases (ICD-9-CM). The 
outcome variable was identified by converting the total hospital charge to hospital cost estimates 
(Hospital Costs = Cost-to-Charge Ratios*Total Charges).78 Using the distribution of total 
hospital cost estimates we categorized hospital cost into increased hospital cost estimates (> 75th 




Neonatal comorbidities associated with hypoglycemia were defined as a dichotomous 
variable using ICD-9-CM codes. In this respect, the presence of any comorbidities associated 
with neonatal hypoglycemia such as jitteriness (796.9), hypotonia (781.3), lethargy (799.22), 
apnea (786.03), tachypnea (786.06), poor feeding (783.3), hypothermia (991.6), sepsis (995.91& 
771.81), seizures (345.x), neurodevelopmental (315.x) deficits were used to create a 
dichotomous variable that indicates the morbidity status of newborns. In addition, demographic 
information (age, sex, and race), region of hospitals (northeast, midwest, south, west), hospitals 
teaching status, bed-size category (small, medium, large), admission date (weekend versus 
weekdays), length of hospital stay (LOS), number procedures performed during hospitalization 
(NPR), number of chronic conditions during hospitalization, expected primary payer, and in-
hospital mortality were extracted for the purpose of the current analysis.  Hospitalization for 
hypoglycemic neonates was categorized into premature and non-premature using the Diagnosis 
Related Groups version 24 (DRG24) codes (386-388). DRG24 is assigned by the Centers for 
Medicare & Medicaid Services (CMS) DRG Grouper algorithm during HCUP processing and it 
has been available since 2006.54  
We used the Kolmogorov-Smirnov test (KS-Test) to assess normality for continuous 
variables. Groups were compared using the Wilcoxon-Mann-Whitney test for continuous 
variables and the χ2 test for categorical variables. For continuous variables data were presented 
in median and interquartile range (IQR). Whereas categorical variables were presented as 
numbers (n) and percentages (%). Odds ratios (OR) for increased hospital cost estimates were 
determined by using bivariate and multivariate logistic regression. All variables that were 




regression analysis. We used this stringent criterion for inclusion in the model because of the 
large sample size. 
A P < 0.05 was considered statistically significant for all tests. SAS® version 9.3 was used 
for the analysis (Institute Inc., Cary, NC, USA). In assessing the calibration of our model, we 
used the Receiver Operating Characteristics (ROC) curve to calculate c statistic and the 
Deviance – Pearson (D-P) goodness of fit statistics.119,120 The two model evaluation measures 
carried out in this study should provide enough assurance regarding the accuracy of our model.   
Results  
 
A total of 3,195,782 hospital discharges were included in the 2012 KID HCUP database, 
from which 1,107,573 were in-hospital births. From the total in-hospital birth, we were able to 
identify 50,650 neonates with hypoglycemia (5%). In 2012, the total hospital cost in neonates 
with hypoglycemia was 821 M$. Since the total cost for in-hospital births was 7,692 M$, 
hospital cost in neonates with hypoglycemia represents 11%. Figure III.1 indicates the relative 
proportion the cost for premature (73%: 602 M$) and non-premature (27%: 219 M$) neonates.  
The median cost estimates in premature and non-premature neonates were $12,755 ($4,550-
$30,339) and $2,360 ($1,153-$3,736), respectively. On the other hand, Figure III.2 represents the 
distribution of hospital cost estimates by primary payer which are divided into Medicaid (50%: 
410 M$), private insurance (44%: 364 M$), Self-pay (1%: 10.7 M$), and other (5%: 36.2 M$). 
In addition, Figure III.3 indicates that the per capita cost estimates among the four United States 
regions, that are northeast (19 K$), Midwest (15 K$), South (14 K$), and West (18 K$). Total 
cost estimates that exceed the 75th percentile ($13,575) was defined as excessive cost associated 




Table III.1 represents characteristics of neonates with hypoglycemia that were 
categorized into two subgroups. We observed that 40% (n=20, 588) of neonates were premature. 
Among infants included in the study, 55% were White, 17% Black, 16% Hispanic, 4% 
Asian/Pacific and 1% Native Americans while 57% and 43% of the neonates were male and 
female. The median values for premature and non-premature neonates were as follows: NPR 2 
(IQR 1-4) and LOS 11 (5-24) and NPR 2 (IQR 0-2) and LOS 3 (2-5), respectively. In 2012, the 
prevalence of hypoglycemia among in-hospital births in the United States was 5 % (n=50,650). 
The results from our multivariate analysis to determine factors associated with increased 
cost estimates among hypoglycemic neonates are presented in Table III.3. Increased costs were 
observed, when more than five procedures were performed during the same hospitalization (OR 
10.13, 95% CI 8.67-11.83, P < 0.0001), when hospital bed size were between 100 and 300 (OR 
1.37, 95 % CI 1.16-1.61, P =0.0002) and ≥ 400 (OR 1.65, 95% CI 1.41-1.92, P < 0.0001), when 
hospital length of stay exceeds 15 days (OR 44.97, 95% CI 41.49-48.73, P < 0.0001), when 
hospitals have teaching status (OR 1.97, 95% CI 1.82-2.13, P < 0.0001), in the case of chronic 
conditions (OR 2.46, 95 % CI 2.27-2.66, P < 0.0001), comorbidity (OR 2.11, 95% CI 1.90-2.35, 
P < 0.0001), prematurity (OR 2.39, 95% CI 2.20-2.60, P < 0.0001), and death (OR 2.95, 95% CI 
2.13-4.09, P < 0.0001). In the unadjusted analysis, all variables included in the models were 
independently associated with increased hospital costs (Table III.2).  
The area under the ROC curve (0.95, 95% CI 0.948-0.953) indicated the predictive 
accuracy of the multivariate model. In addition, the results from the D-P goodness of fit (d= 
3820, df =3722) also expressed that the values for deviance (d) are not much larger than their 
degrees of freedom, suggesting that the fitted model cannot be rejected and leads to the 






Our analysis of the 2012 HCUP KID database shows that hospital cost estimates in 
neonates with hypoglycemia consumed 11% of the resources associated with hospital births. We 
determined a 5% prevalence of neonatal hypoglycemia among in-hospital births in the U.S 
during the year 2012. We also determined that medium and large hospital bed sizes, LOS, NPR, 
teaching hospitals, composite neonatal comorbidities, prematurity, occurrence of chronic 
conditions, and mortality were independently associated with increased hospital cost estimates in 
neonates with hypoglycemia.  
Previous studies have focused on estimations of the economic cost of hypoglycemia in 
the adult population.44-49 To our best knowledge, this is the first study providing an empirical 
estimate of the hospital cost of neonatal hypoglycemia at the national level. It is worth noting 
that 100% of mortality and higher morbidity (51%) occurred in the non-premature group. As 
premature neonates are usually treated in neonatal intensive care units that provide around-the-
clock care, non-premature babies appear to be prone to mortality and various hypoglycemia 
related comorbidities. Furthermore, since premature neonates are more likely to be delivered by 
caesarian section, non-premature neonates are at increased risk for serious birth related 
morbidities such as birth trauma.70 This result is consistent with previous studies16,41,77,121 in that 
neonates with asymptomatic hypoglycemia may easily be neglected of proper care which may 
lead to acute comorbidities and even death. As the majority of hypoglycemic cases are 
asymptomatic, enough emphasis should be given this subgroup.   
At this juncture, an explanation of the cost-to-charge ratios (CCRs) is warranted. The 
HCUP KID contains data on total charges for each hospital in the databases. This charge 




much hospital services actually cost.54 Cost information was obtained from the hospital 
accounting reports collected by the CMS. Statistical imputation for missing values and internal 
validation studies were carried out to enhance the accuracy of the CCRs.75,77 Most hospital-based 
studies use total charge as a proxy measurement for actual cost.53 This may lead to drawing 
unwarranted conclusions about economic efficiency and hospital resource utilizations.53 To 
maximize the accuracy of the cost estimation, our study used actual cost by converting the total 
hospital charge to hospital cost estimates using CCRs.  
We recognize that there are some limitations associated with this study. The ICD-9-CM 
classification system is imperfect for case identification, as it was created for reimbursement 
rather than research purposes. As a result, important clinical conditions pertinent for neonatal 
outcome research may have been missed. Because KID 2012 lacks individual identifiers for 
states, we were not able to conduct comparative analysis among various states. However, despite 
the potential limitations, the HCUP KID database is the largest validated and publicly available 
all-payer pediatric inpatient care database54 that can be used to evaluate national cost estimates, 
resource utilization, and economic burden of hospitalization in the pediatric population.  
Conclusion 
 
This study demonstrated that neonates with hypoglycemia consumed 11% of resources 
associated with hospital births while accounting for only 1.5% of hospitalization. We also 
determined that hospital length of stay, hospital bed size, teaching hospitals, number of 
procedures performed during hospitalization, chronic conditions, comorbidity, prematurity, and 
in-hospital mortality were independently associated with increased hospital cost. Our results also 
suggested that non-premature hypoglycemic babies should be provided with more care to reduce 




Table III.1. Characteristics of Neonates with Hypoglycemia by Prematurity Status 
 
Variables Premature  








P Value  
Gender n, (%)    <.0001 
 Male  10,781(37.11) 18,269 (62.89) 29,050 (57.38)  
 Female  9,800 (45.42) 11,778 (54.58) 21,578 (42.62)  
Race n, (%)    <.0001 
White 9,826 (38.88) 15,448 (61.12) 25,274 (55.40)  
Black 3,599 (47.11) 4,041 (52.89) 7,640 (16.75)  
Hispanic 2,893 (40.80) 4,197 (59.20) 7,090 (15.54)  
Asian/Pacific  714 (38.02) 1,164 (61.98) 1,878 (4.12)  
Native Americans 170 (38.99) 266 (61.01) 436 (0.96)  
Admission Day n, (%)    <.0001 
Weekday 15,816 (39.51) 24,216(60.49) 40,032 (79.04)  
Weekend  4,772 (44.94) 5,846 (55.06) 10,618 (20.96)  
Hospital n, (%)    <.0001 
Teaching  12,952 (44.64) 16,060 (55.36) 29,012 (57.28)  
Non-Teaching  7,636 (35.29) 14,002 (64.71) 21,638 (42.72)  
Bed Size n, (%)    <.0001 
Small (1-99) 1,310 (30.83) 2,939 (69.17) 4,249 (8.39)  
Medium (100-399) 5,071 (39.19) 7,869 (60.81) 12,940 (25.55)  
Large (≥ 400) 1,4207 (42.46) 19,254 (57.54) 33,461 (66.06)  
Ownership n, (%)    <.0001 
Private  15,161 (40.58) 22,200 (59.42) 37,361 (73.76)  
Public 5,427 (40.84) 7,862 (59.16) 13,289 (26.24)  
Morbidity n, (%) 2,982 (49.01) 3,102 (50.99) 6,084 (12.01) <.0001 
Mortality n, (%) 0 (0) 389 (100) 389 (0.77)  
NPR#* 2 (1-4) 2 (0-2) 4 (2-11) <.0001 
LOS days +* 11 (2-24) 3 (2-5) 1 (0-3) <.0001 
+LOS, Hospital length of stay in days; #NPR, number of procedure. Data are presented in number (n) and 










Table III.2. Unadjusted ORs, 95% CIs, and P Values from Bivariate Logistic Regression 
Analysis Associated with Increased Cost Estimates (>75th Percentile) 
 
Variables  Unadjusted OR B (SE) 95% CI P value 
Female 1.20 0.19 (0.02) 1.16 1.26 <.0001 
Black  1.65 0.50 (0.03) 1.55-1.74 <.0001 
Hispanic  1.37 0.31 (0.03) 1.29-1.45 <.0001 
Asian/Pacific  1.41 0.34 (0.05) 1.27-1.56 <.0001 
Native Americans  1.10 0.10 (0.11) 0.88-1.38 0.3721 
Weekend 1.14 0.14 (0.02) 1.09-1.20 <.0001 
Medium (100-399) 1.91 0.65 (0.05) 1.74-2.10 <.0001 
Large (≥ 400) 2.24 0.80 (0.05) 2.05-2.45 <.0001 
Teaching Hospital  2.28 0.83 (0.02) 2.19-2.39 <.0001 
LOS+ >15 days  95.36 4.56 (0.03) 89.32-101.82 <.0001 
NPR# >5 43.21 3.77 (0.05) 38.93- 47.96 <.0001 
Chronic Condition  5.82 1.76 (0.02) 5.57-6.08 <.0001 
Death  6.01 1.79 (0.11) 4.87-7.42 <.0001 
Premature 8.95 2.19 (0.02) 8.53-9.38 <.0001 
Morbidity 3.45 1.24 (0.03) 3.26-3.64 <.0001 
OR, odds ratio; B, regression coefficient; SE, standard error; CI, confidence interval;  +LOS, Hospital 






Table III.3. Adjusted ORs, 95% CIs, and P Values from Multivariate Logistic Regression 
Analysis Associated with Increased Cost Estimates (>75th Percentile) 
 
Variables  Adjusted OR B (SE) 95% CI P value 
Female 1.01 0.01 (0.09) 0.94-1.09 0.7439 
Black  0.89 -0.12 (0.05) 0.8.0-0.98 0.0185 
Hispanic  1.26 0.23 (0.05) 1.13-1.39 <.0001 
Asian/Pacific  1.95 0.67 (0.09) 1.63-2.32 <.0001 
Native Americans  1.57 0.45 (0.19) 1.09-2.28 0.0163 
Weekend 1.04 0.04 (0.05) 0.95-1.14 0.3816 
Medium (100-399) 1.37 0.31 (0.08) 1.16-1.61 0.0002 
Large (≥ 400) 1.65 0.50 (0.08) 1.41-1.92 <.0001 
Teaching Hospital  1.97 0.68 (0.04) 1.82-2.13 <.0001 
LOS >15 days  44.97 3.81 (0.04) 41.49-48.73 <.0001 
NPR >5 10.13 2.32 (0.08) 8.67-11.83 <.0001 
Chronic Condition  2.46 0.90 (0.04) 2.27-2.66 <.0001 
Death  2.95 1.08 (0.17) 2.13-4.09 <.0001 
Premature 2.39 0.87 (0.04) 2.20-2.60 <.0001 
Morbidity 2.11 0.75 (0.05) 1.90-2.35 <.0001 
OR, odds ratio; B, regression coefficient; SE, standard error; CI, confidence interval;+LOS, 











Figure III.1. Total Cost Estimates in Neonates with Hypoglycemia by Prematurity Status. Total 
















Figure III.2. Total Cost Estimates in Neonates with Hypoglycemia by Primary Payer. Total Costs 
Are Expressed In Million US Dollars (M$) and Divided Among Private Insurance, Medicaid, 


















Figure III.3. Per Capita Cost Estimates in Neonates with Hypoglycemia by Region. Per Capita 
Costs Are Expressed In Thousand US Dollars (K$) For Four US Regions: Northeast, Midwest, 











PROJECT III: A MULTILEVEL MODELING ANALYSIS OF 





Neonatal hypoglycemia is the most common metabolic abnormality in infants and is 
associated with neurological damage and death.4 Estimates for neonatal hypoglycemia are 
between 3% and 29% of all pregnancies in the United States.122 As glucose is an essential 
primary substrate for the brain,4,122 neurons, and glial cells are susceptible to hypoglycemia.84 
Neonates with hypoglycemia are prone to various acute84 and chronic health problems.43,123 In 
the short run, newborns may experience jitteriness, hypotonia, lethargy, irritability, apnea, 
tachypnea, poor feeding, hypothermia, and seizures.55 Later in their life, they may experience a 
neurodevelopmental delay or even death.55,124 Due to poor nutritional status, infectious diseases, 
and the lack of diagnostic facilities, neonatal hypoglycemia in resource poor countries has far 
more serious consequences for health.124 The risk of developing hypoglycemia among infants 
born from diabetic mothers is even higher.6  
For neonates to have a normal brain, adequate supply of glucose during infancy is 
crucial.70 Therefore, the lack of this essential substrate at the early stage of growth may lead to 
various acute122 and long term43 life-threatening medical conditions. Hypoglycemia occurs in 
approximately 3-20% of neonates born to mothers with diabetes6,55,124, with an estimated 
incidence rate of approximately 27% among infants born to women with diabetes compared to 
3% among full-term healthy infants born to non-diabetic women.35,36 Previous research on 




factors such as poor maternal glycemic control, neonatal weight at birth, and gestational age at 
delivery as predisposing risk factors for the development of neonatal hypoglycemia in diabetic 
pregnancies. However, contextual risk factors such as neighborhood economic status, type of 
insurance, hospital characteristics, and regional variations were not considered in these studies.  
Neonatal hypoglycemia is a highly preventable medical condition71 and yet it poses a 
significant threat to the health of newborns. Due to lack of adequate knowledge about the 
potential individual and contextual risk factors, the prevention of neonatal hypoglycemia has 
been difficult.57, 125 Therefore, considering these multilevel characteristics in assessing the 
determinants of neonatal hypoglycemia is necessary to understand the complex relationship 
among various influencing factors. In addition, since neonatal hypoglycemia is strongly 
associated with poor maternal health33,72,73, the identification of the risk factors is important to 
improve the mothers’ health through effective prevention measures that can reduce high-risk 
pregnancies.  
The purpose of the current study was to construct multilevel models that include 
individual-level and contextual-level characteristics in order to predict neonatal hypoglycemia in 
diabetic and non-diabetic mothers. We hypothesized that infants born from diabetic mothers will 
have significantly higher chance of developing hypoglycemia compared to those born from non-
diabetic mothers. The addition of the contextual-level factors was also expected to enhance the 
predictive power of the models. Addressing these issues using a large nationally representative 
database is necessary to guide the prevention and control of adverse health outcomes associated 
with hypoglycemia in these priority populations. 





The current study used the 2012 Kid’s Inpatient Database (KID) developed by the 
Healthcare Cost and Utilization Project (HCUP). The proposed research is a cross-sectional 
study that examines hospital discharges of newborn infants delivered after complicated or 
uncomplicated pregnancies.  
The KID is the largest publicly available all-payer pediatric (≤20 years of age) inpatient 
care database in the United States. The 2012 KID database includes 4179 hospitals and 
3,195,782 pediatric discharges. HCUP categorize hospital regions as northeast, mideast, south, 
and west. In addition to demographic and clinical measures, hospital ownership, teaching status, 
location, bed size, and other important hospital characteristics were also included in the database.  
In total, 70 children’s hospitals (400,835 pediatric discharges) and 4,109 hospitals that admit all 
patients (2,794,947 pediatric discharges) were included in the 2012 database. As we are 
interested only in neonates, this analysis is limited to uncomplicated and complicated in-hospital 
births. Hospital discharges with missing, invalid, or inconsistent ages were excluded from the 
HCUP KID.  
For sampling, pediatric discharges were stratified by uncomplicated in-hospital birth, 
complicated in-hospital birth, and all other pediatric cases. For an accurate representation of each 
hospital’s pediatric case-mix, the discharges were sorted by State, hospital, diagnosis-related 
group (DRG), and a random number within each DRG. Then, systematic random sampling was 
used to select 10% of uncomplicated in-hospital births and 80% of complicated in-hospital births 
and other pediatric cases from each sampling frame hospital. To obtain national estimates, 
discharge weights were developed using the American Hospital Association universe as the 
standard. This is the first study that proposed to use a nationally representative database to 






Subjects were eligible to be included in the study if they were neonates (first 28 days 
after birth), had a diagnosis of hypoglycemia (ICD-9-CM=775.6), and were born in the 44 
HCUP participating States in the year 2012. All other pediatric cases occurred in the United 
States community, non-rehabilitation hospitals were excluded from the study.   
Variables  
 
The current study included both individual and contextual level characteristics of 
neonatal hypoglycemia. International classification of diseases, 9th version (ICD-9-CM codes), 
Diagnostic Related Groups (DRGs), Clinical Classifications Software Category (DXCCS1-
DXCCS25), and Clinical classification software category for all procedures (PRCCS1- 
PRCCS15) were used to extract the independent variables. The dependent variable, neonatal 
hypoglycemia, was extracted as dichotomous variables using the ICD-9-CM code 775.6. The 
complete list of codes used to identify variables are listed in Appendix A.  
The individual characteristics included in the analysis were gender, race, prematurity, 
small-for-gestational age (birth weight <10th percentile), large-for-gestational-age (birth weight 
>90th percentile), mortality, addmission type (scheduled, non-scheduled), addmision day 
(weekend, weekday), indicator of emergecy service use, comorbidities including jitteriness, 
hypotonia, lethargy, irritability, apnea, tachypnea, poor feeding, hypothermia, sepsis, seizures, 
neurodevelopmental deficits. An indicator of maternal diabetes status (Type I, Type II, or 
Gestational), history of substance/alcohol abuse, and delivery mode (caesarian, normal) were 
included as individual characteristics associated with the mother.  
Contextual variables such as region (Northeast, Midwest, South, West), insurance type 




patient’s zip code ($1-$38999, $39000-$47999, $48000-$62999, $63000+), admission season 
(January-March, April-June, July-September, October-December), hospital bed size (1-99, 100-
399, ≥ 400), ownership (public, private), teaching status, and location (rural, urban) were 
included in the analysis. 
Statistical Analysis 
 
For the purpose of our analysis, the inpatient core file and the hospital file were used. All 
analyses were weighted to account for the complex probability sampling of the dataset and 
permit inferences regarding the risk factors for neonatal hypoglycemia. Descriptive and 
inferential statistics were performed taking complex survey design into consideration. Groups 
were compared using the Rao-Scott χ2 test for categorical variables. Values were presented as 
numbers (n), percentages (%), and odds ratios (OR).  
Hierarchical logistic regression models were constructed to simultaneously examine 
individual and contextual predictors of neonatal hypoglycemia. The proposed statistical analysis 
is appropriate because of 1) the nested structure of the data and 2) unlike ordinary least squares 
models, hierarchical models enable us to investigate and explain the sources of both the within 
and between variations of higher-level factors. Random-intercept models were applied to identify 
key factors that can independently predict neonatal hypoglycemia among diabetic and non-
diabetic mothers. A p value < 0.05 was considered statistically significant for all tests. SAS® 
version 9.3 was used for data analysis (Institute Inc., Cary, NC, USA).    
Hierarchical Modeling Scheme  
 
Multilevel or hierarchical models have been developed to properly account for the 
hierarchical nesting of data126-129. Such modeling techniques should be used in health services 




nature. Conducting research ignoring the hierarchical structure of the data can lead to erroneous 
conclusions such as incorrect estimation of variances and the available power to detect covariate 
effects130-133, increase Type I error rates134, underestimate standard errors, and lead to substantive 
errors in interpreting the results of statistical significance tests.135 To avoid these potential 
systematic and analytical errors, the current study followed a step-by-step procedure for building 
hierarchical models. The fundamental theoretical underpinnings of hierarchical modeling are 
presented in Appendix B.   
Model Building Process  
 
To estimate the most parsimonious models that best fit the data, the following three 
distinct model building processes were conducted. First, intercept-only model or unconditional 
model were carried out. The intercept-only model was used to calculate the intra-class 
correlation coefficient (ICC) which estimates how much variation in neonatal hypoglycemia 
exists between level-2 unit (i.e. hospitals). Second, level-1 fixed effects were added to a model to 
assess the relationship between level-1 predictors (i.e. individual level characteristics) and 
neonatal hypoglycemia. Third, level-2 predictors (contextual characteristics) were added to the 
final model to evaluate the fixed effects of both individual and contextual characteristics (Table 
IV.1). Forward selection methods (P ≤ 0.10) were used to identify variables that were eligible for 
the multivariate analyses. 
To assess the model fit, a likelihood ratio test which examines differences in the -2 log 
likelihood (-2LL) were conducted. Since all models in the current analysis were nested (i.e., 
models that have been fit using the same data and where one model is a subset of the other), 






 A weighted total of 3,733,760 in-hospital births were included in the 2012 KID’s 
inpatient database (Table IV.2). A total of 67,124 (5%) neonates were hypoglycemic. Among 
neonates included in the study 51% of the neonates were male, while 52% were White, 14% 
Black, 20% Hispanic, 13% Other (Asian/Pacific and Native Americans). Among neonates with 
hypoglycemia 50% were small for gestational age, 15% were large for gestational age, 12% had 
comorbidities, 40% were premature, 44% were delivered by cesarean section, 30% were born 
from mothers with diabetes, and 2% of the births were associated with mothers with history of 
substance/alcohol abuse. Almost all mothers were admitted through non-scheduled admission 
(99%) and close to 80% of births occurred during weekdays.   
 The majority of newborns had some form of insurance coverage including 46% with 
Medicaid, 46% with private insurance, and 7% with other types of coverages (self-pay and no 
charge) (Table IV.3).  The median household income in the zip code of patient’s residence were 
proportionately distributed into 28% ($1-$38,999), 25% ($39,000-$47,999), 25% ($48,000 - 
$62,999), and 22% ($63,000 and above). The majority of births occurred in urban hospitals 
(88%), in hospitals with bed size greater than or equal to 400 (36%) between July and September 
(27%). Furthermore, the majority of hospitals were large (63%), privately owned (72%) and well 
distributed geographically among the four hospital regions including Northeast (17%), Midwest 
(21%), South (38%), and West (24%). Fifty-seven percent of neonates with hypoglycemia were 
born in teaching hospitals. Proportionate percentages of births were also observed in teaching 
(50%) and non-teaching hospitals (50%). 
 Table IV.4 reports the results from the random intercept model that shows the bivariate 
relationship between the specified variables and neonatal hypoglycemia. In this analysis male 




0.77-0.81) and Other race (Asian/Pacific and Native Americans, OR 0.8, 95% CI 0.82-0.87), 
morbidity (OR 2.7, 95% CI 2.57-2.73), small for gestational age (OR 9.6, 95% CI 9.41-9.72), 
large for gestational age (OR 2.9, 95% CI 2.81-2.95), prematurity (OR 7.0, 95% CI 6.78-7.15), 
delivery by caesarian section (OR 1.9, 95% CI 1.79-1.85), diabetes status (OR 5.6, 95% CI 5.46-
5.65), history of substance/alcohol abuse (OR 1.2, 95% CI 1.08-1.22), scheduled delivery (OR 
0.8, 95% CI 0.64-0.92), emergency service use (OR 1.5, 95% CI 1.17-2.00), admission between 
July and September (OR 1.1, 95% CI 1.03-1.08), admission between October and December (OR 
1.1, 95% CI 1.06-1.11), neighborhood income above $63,000 (OR 0.9, 95% CI 0.94 - 0.99), 
teaching hospitals (OR 1.7, 95% CI 1.58-1.87), medium hospital bed size (OR 1.2, 95% CI 1.04 - 
1.29), large hospital bed size (OR 1.4, 95% CI 1.26-1.55), privately owned hospitals (OR 1.1, 
95% CI 1.05-1.24), urban hospitals (OR 2.0, 95% CI 1.84-2.24), and Medicaid insurance (OR 
1.2, 95% CI 1.01-1.35) were significantly associated with neonatal hypoglycemia.  
 Using the estimate obtained from the empty model, the intra-class correlation coefficient 
(ICC) which indicates how much of the total variation in the probability of neonatal 
hypoglycemia is accounted for by the hospitals was calculated. Hierarchical model assumes that 
the dichotomous outcome from the hierarchical model comes from an unknown latent continuous 
variable with a level-1 residual that follows a logistic distribution with a mean of 0 and a 
variance of 3.29. 136,137 As a result, 3.29 were used as the level-1 variance (VP) while the hospital 
variance (VH =0.8381) were obtained from the model.  
ICC = VH / [(VH+VP)]*100 
ICC = [0.8381 / (0.8381+3.29)]*100 = 20% 
The above calculation indicates that 20% of the variability in the rate of neonatal 




patients. The result also indicates that there is a statistically significant amount of variability 
(VH=0.8381; Z = 26.74; p <.0001) in the odds of developing hypoglycemia between the 
hospitals. 
The model that was constructed to observe the relationship between individual level 
predictors and neonatal hypoglycemia (model 2) is presented in Table IV.5. In this multivariate 
analysis female sex (OR 0.8, 95% CI 0.81-0.85), Hispanic (OR 0.8, 95% CI 0.78-0.83), Other 
race (Asian/Pacific and Native Americans, OR 0.9, 95% CI 0.84-0.90), morbidity (OR 2.6, 95% 
CI 2.49-2.66), small for gestational age (OR 3.9, 95% CI 3.82-3.98), large for gestational age 
(OR 2.8, 95% CI 2.76-2.92), prematurity (OR 1.9, 95% CI 1.87-1.99), delivery by caesarian 
section (OR 1.4, 95% CI 1.38-1.44), diabetes status (OR 2.0, 95% CI 1.95-2.04), history of 
substance/alcohol abuse (OR 1.2, 95% CI 1.10-1.25), scheduled delivery (OR 0.8, 95% CI 0.64 - 
0.92), and emergency service use (OR 1.4, 95% CI 1.02-1.82) were significantly associated with 
neonatal hypoglycemia.  
 The final model that combines both the individual and contextual level predictors is 
presented in Table IV.6. In this analysis male sex (OR 1.2, 95% CI 1.18-1.23), Hispanic (OR 0.7, 
95% CI 0.61-0.80) and Other race (Asian/Pacific and Native Americans, OR 0.8, 95% CI 0.78-
0.91), morbidity (OR 5.0, 95% CI 4.63-5.40), small for gestational age (OR 9.7, 95% CI 9.25-
10.27), large for gestational age (OR 3.1, 95% CI 2.86-3.34), prematurity (OR 3.8, 95% CI 3.44-
4.15), delivery by caesarian section (OR 1.5, 95% CI 1.50-1.59), diabetes status (OR 5.1, 95% CI 
4.81-5.41), history of substance/alcohol abuse (OR 2.1, 95% CI 1.92-2.29), weekend admission 
(OR 1.1, 95% CI 1.03-1.08), emergency service use (OR 1.5, 95% CI 1.10-2.00), teaching 
hospitals (OR 1.2, 95% CI 1.10-1.34), and urban hospitals (OR 1.4, 95% CI 1.21-1.52) were 




The best fitting models were determined by using a likelihood ratio test which examines 
differences in the -2 log likelihood (-2LL). Accordingly, Model 1 to Model 2 and then Model 2 
to Model 3 were compared. The calculations for conducting the test between Model 1 and Model 
2 is provided below. The positive value (χ2diff=291,922.9) obtained from the equation 1 shows 
that model 2 is a better model than model 1.   
χ2diff=(−2LLModel 1) −  (−2LLModel 2 )………………………equation 1 
χ2diff= (641,605.2) - (349,682.3) 
χ2diff= 291,922.9 
χ2diff=(−2LLModel 2) −  (−2LLModel 3 ) ………………………equation 2 
χ2diff= (349,682.3) - (52,276.9) 
χ2diff= 297,405.4 
 
After determining that Model 2 was a better fitting model than Model 1, a comparison 
between Model 2 and Model 3 was made to examine whether the addition of the contextual level 
variables improved the final model. The calculation from equation 2 (χ2diff=297,405.4) also 
indicates that contextual level variables did improve the final model.  This process showed that 
Model 3, a model containing both the individual and contextual level fixed effects, was the best 
fitting model.    
Discussion   
 
In our analysis of the 2012 HCUP KID database, which included more than 3.7 million 
patient discharges, indicated a 5% (67,124) prevalence of neonatal hypoglycemia. Among 
hypoglycemic neonates, we determined that 30% of neonates were born from diabetic mothers 




for gestational age, large for gestational age, prematurity, delivery by caesarian section, diabetes 
status, history of substance or alcohol abuse, scheduled delivery, emergency service use, urban 
hospitals, and teaching hospitals were significantly associated with neonatal hypoglycemia. As 
20% of the variability in the rate of neonatal hypoglycemia is accounted by the hospitals, our 
specification of hierarchical modeling was appropriate to account for the variability among 
hospitals. 
In our analysis the most robust association, as evidenced by the statistical significance in 
the multivariate analysis, was found between the individual level characteristics and neonatal 
hypoglycemia. Our main hypothesis was confirmed by the strong association found between 
neonatal hypoglycemia and diabetic mothers. Statistically significant associations were found 
both in the bivariate random intercept model (OR 5.6) and multivariate model (OR 5.1). Most 
studies of neonatal hypoglycemia not only focused on clinical risk factors but also used small 
databases from single medical facilities without having proper comparison groups. Our study is 
unique in that we used a large nationally validated database to determine the individual and 
contextual risk factors of neonatal hypoglycemia both in diabetic and non-diabetic mothers. The 
results of the current study highlight the high increased risk (5 fold) of neonatal hypoglycemia 
among diabetic mothers compared to non-diabetic mothers at the national level. As neonatal 
hypoglycemia is associated with acute and potentially permanent neurological damage4,138, 
hospitals across the United States should develop a more effective method and devise 
management strategies to identify fetuses from diabetic mothers so that intervention during the 
neonatal period can be made.  
 Pertaining to the association between the other individual level risk factors and neonatal 




et al.10 found that large for gestational age or macrosomic infants had 3.5 fold higher odds of 
developing hypoglycemia compared to non-macrosomic infants. Higher frequencies of maternal 
diabetes and large for gestational age infants were also observed by Flores-le Roux et al.13 and 
VanHaltren et al.34 Similar to our findings, Ramos et al.23 indicated that hypoglycemia was 
statistically associated with prematurity, macrosomia, and Ponderal index, a measure of fetal 
adiposity. Furthermore, similar to the current analysis, Tundidor et al.101 found that male sex as 
an independent predictor of neonatal hypoglycemia (OR 2.13). Female newborns are more 
insulin resistant than boys156, and this might suggest that male infants might be more prone to 
neonatal hypoglycemia. Das et al.70 and Ecker et al.155 also found a higher percentage of 
caesarian section among infants of diabetic mother compared to infants of non-diabetic mothers 
which is in agreement with our findings.  It is also worth noting that infants born from mothers 
with a history of substance/alcohol abuse were prone to hypoglycemia (OR 2.1).  
The Hispanic health paradox was also observed in our study. The paradox states that, 
despite lower socioeconomic status Hispanics have comparable or better health outcomes than 
whites. 139,140 Similar to what the paradox states, we found that Hispanic neonates were 30% less 
likely to develop neonatal hypoglycemia compared to whites (Table IV.6). Lower birth trauma, 
protective dietary practices, better breastfeeding habits, and strong social networks and support 
are thought to be the main factors explaining these paradoxical result.141 Overall, the findings 
related to the individual risk factors examined by the current study were consistent with the 
literature.  
This is the first study to incorporate contextual characteristics in determining risk factors 
for neonatal hypoglycemia. Significant associations were observed in the relationship between 




neighborhood income above $63,000 (OR 0.9), teaching hospitals (OR 1.7), large hospital bed 
size (OR 1.4), privately owned hospitals (OR 1.1), urban hospitals (OR 2.0), and Medicaid 
insurance (OR 1.2) were significantly associated with neonatal hypoglycemia. In the multivariate 
analysis, however, only urban (OR 1.4) and teaching hospitals (OR 1.2) were significantly 
associated with neonatal hypoglycemia.  
Among the contextual characteristics, therefore, only urban and teaching hospitals had a 
significant association with neonatal hypoglycemia. Although no studies were conducted to 
determine the association of hospital characteristics and neonatal hypoglycemia, our findings 
were consistent with studies that compared other health outcomes in teaching versus non-
teaching and urban versus rural hospitals. The apparent differences in neonatal health outcome in 
these hospitals could be explained by 1) the quality of care that the hospitals provide and 2) the 
overall health status of mothers who choose to get services in these hospitals.   
The poorer neonatal health outcome in urban hospitals may be due to significant 
variations in organizational and service mix characteristics that urban and rural hospitals 
have.142,143 The literature on health care outcomes in urban versus rural hospitals shows that 
urban hospitals have higher rates of caesarian section, lower patient safety outcomes, higher 
adverse event rates, higher rates of infection due to medical care, lower quality of care, and 
higher rates of pregnancy complication.144,145 Higher rate of insurance coverage in rural area and 
younger age of rural mothers could also be the reason for the relatively better neonatal outcomes 
in rural hospitals.145,146 In order to balance neonatal outcomes between urban and rural hospitals, 
targeted intervention efforts that incorporate the particular healthcare needs of rural communities 




Regarding neonatal outcomes in teaching hospitals, our findings were also consistent 
with data from the literature. Differences in neonatal health outcome in these hospitals could also 
be caused by the quality of care or the overall health status of mothers who received care in these 
hospitals. Sloan et al.147 found that teaching hospitals had higher postoperative complications in 
four of six surgical procedures considered in the study. In a study that included 16.9 million 
Medicare patients, Yuan et al.148 found that teaching hospitals had the highest mortality rates. In 
a study that included hospitals of Veterans Affairs, Khuri et al.149 also found that complication 
rate was higher in teaching hospitals in six of seven specialties and four of eight operations.  
In the current study, one can also presume that the difference in neonatal health outcomes 
between teaching and non-teaching hospitals may be attributable to differences in the processes 
of care. Teaching hospitals, for example, have a more complex structure involving multiple 
levels of providers including medical students, interns, residents, and fellows, they serve as 
referral centers for complex services and procedures, and most of them provide care for urban 
underserved populations.150, 151 Furthermore, since residents are the primary care provider in 
teaching hospitals149,152, there is a possibity that hypoglycemic neonates might be overlooked 
during delivery.  
Improving the quality care during pregnancies is crucial to prevent neonatal 
hypoglycemia. For example, maternal blood glucose level in labor is independently associated 
with neonatal hypoglycemia.100 Providing standardized management for diabetic women in labor 
using an intravenous insulin-glucose protocol is effective in achieving stable maternal blood 
glucose levels99 and reduce neonatal hypoglycemia. With the ongoing emphasis on quality of 




neonatal health outcomes. Efforts should be made to examine further the structures and processes 
of neonatal care prevailing in teaching and urban hospitals. 
The current study was unique in several ways. First, the study used a nationally validated 
database to assess risk factors of neonatal hypoglycemia. A large national database containing 
millions of patient-level records has not been utilized in determining predictors of healthcare 
outcomes related to neonatal hypoglycemia. As a result, the focus of previous research in this 
area has been limited to assessing clinical risk factors using data generated from individual 
hospitals. Second, due to the availability of a large database, we were able to include individual 
and contextual characteristics in our analysis that were not considered in the past. Third, by 
applying hierarchical models and taking complex survey design into consideration, we were able 
to investigate and explain the sources of both within-hospital and between-hospital variations. 
Although the use of hierarchical models is increasing, most studies using clustered data in the 
health services literature have used ordinary least squares models (OLS). The use of OLS models 
in clustered data tends to underestimate standard errors for the regression coefficient, resulting in 
inflated type I error rates and misleadingly tight confidence intervals.153 By specifying the 
appropriate hierarchical models, the current study ensured better inferences and yielded more 
information than results that would have been obtained from traditional standard regression 
models. 
We also identified the limitations associated with the study. First, because of the structure 
of the KID, we were not able to track patients over time to determine long term health impact of 
neonatal hypoglycemia on, for example, neurological and cognitive developments. Therefore, 
interpretation of the results should consider the retrospective cross-sectional nature of the study 




Although the variables included in the study are sufficient to understand the overall risk factors 
of neonatal hypoglycemia, variables such as maternal age, educational background, and 
individual income could have provided more insightful results. HCUP should consider these 
variables in future preparations of the KID inpatient databases. Third, only 44 states participate 
in the HCUP. Furthermore, as the data include only community, non-rehabilitation hospitals, 
other types of hospitals such as Veterans’ Administration and Indian Health System facilities 
were not included in the data. Our findings may have been underestimated by the exclusion of 
states and hospitals. Finally, we recognize that errors in providers’ understanding of diagnostic 
coding/groupings may lead to misclassifications of cases. Despite these limitations, however, the 
KID database is the only nationally validated database that is available to conduct outcomes 
research on the pediatric population and the use of such validated databases should be 
encouraged in other areas of health services research.  
Conclusions and Recommendations  
 
The purpose of the current study was to construct multilevel models that include 
individual-level and contextual-level characteristics in order to identify risk factors of neonatal 
hypoglycemia in diabetic and non-diabetic mothers. We found that infant of diabetic mothers has 
more than 5-fold increased risk of developing neonatal hypoglycemia compared to infants of 
non-diabetic mothers. In addition, the increased risk of neonatal hypoglycemia in male, 
premature, small for gestational age, large for gestational age, and neonates born from mothers 
with a history of substance or alcohol abuse were also the most relevant results associated with 
the individual risk factors. Increased awareness of neonatal hypoglycemia in these subgroups 
should be encouraged to improve and changes clinical practices across hospitals in the United 




significantly higher chance of developing neonatal hypoglycemia. Future research should focus 
on the long term clinical significance of neonatal hypoglycemia by including a broader 
individual and environmental factors. 
Neonatal hypoglycemia is a highly preventable medical condition and yet it poses a 
significant health threat to the newborns including long-term neurological damage resulting in 
mental retardation, developmental delay, and personality disorders.39,49,154 In order to prevent and 
improve the clinical practices of hypoglycemia the following recommendations, based on the 
findings from the current study, are forwarded: 
1. We found that the individual level risk factors have the most robust association with 
neonatal hypoglycemia. Therefore, triage treatment system can be developed based on 
whether the neonate has the specified individual level risk factors. For example, as infants 
of diabetic mothers have more than 5-fold increased risk of developing hypoglycemia, 
priority should be given to all diabetic mothers in order to facilitate early diagnosis and 
treatment of hypoglycemia. Special attention should also be given to infants that are male, 
premature, small for gestational age, large for gestations age, infants with comorbidities, 
infants delivered by caesarian section and those born from mothers with a history of 
substance abuse. 
2. Treatment of neonatal hypoglycemia oftentimes involves admission to Neonatal Intensive 
Care for intravenous dextrose which is costly and disruptive for the establishment of 
breast feeding.157 As evidenced by the current study, most of the risk factors can be 
prevented by establishing a well thought-out parental care in hospitals across the United 




3. In order to balance neonatal outcomes between urban and rural hospitals, targeted 
intervention efforts that incorporates the particular needs of these hospitals should be 
introduced. Furthermore, with the ongoing emphasis on quality of care, the role of 
teaching and urban hospitals needs to be carefully scrutinized with regard to neonatal 
health outcomes. Efforts should also be made to examine further the structures and 





Table IV.1. Model Building Process for Hierarchical Logistic Regression 
Models  Variables  Expected Output  
Model-1 Empty model, no predictors, 
only random effect for the 
intercept 
Output used to calculate ICC 
which provides information on 
how much variation in neonatal 
hypoglycemia exists between 
level-2 units 
 
Model-2 Model 1 + fixed effect for 
individual level variables 
Output indicate the relationship 
between individual level 
predictors and neonatal 
hypoglycemia 
 
Model-3 Model 2 + fixed effect for 
contextual level variables 
Contextual level fixed effect 
results indicate the relationship 
between contextual level 
predictors and the neonatal 
hypoglycemia. Model 3 also 






Table IV.2. Individual Level Characteristics of Neonates with Hypoglycemia 
Variables Hypoglycemic  Non-Hypoglycemic Total P Value  
Unweighted sample n 51,880  1,055,693 1,107,573  
Weighted population size n 67,124  3,666,636 3,733,760  
Gender n, (%)     
Male  38,495 (57.38) 1,868,004 (50.97) 1,906,499 (51.09) <.0001 
Female  28,598 (43.62) 1,796,628 (49.03) 1,825,227 (48.91)  
Race n, (%)     
White 33,575 (55.35) 1,757,304 (52.34) 1,790,879 (52.39) <.0001 
Black 10,129 (16.70) 479,259 (14.27) 489,388 (14.32)  
Hispanic 9,459 (15.59) 675,793 (20.13) 685,252 (20.05)  
Other$ 7,493 (12.35) 445,429 (13.27) 452,922 (13.25)  
SGA n, %     
SGA£ 33,808 (50.37) 348,156 (0.09) 381,964 (10.23) <.0001 
Non-SGA 33,316 (49.63) 3,318,480 (99.91) 3,351,796 (89.77)  
LGA n, (%)     
LGA¥  9,723 (14.49) 204,808 (6.00) 214,532 (5.75) <.0001 
Non- LGA 57,401 (85.51) 3,461,828 (94.00) 3,519,228 (94.25)  
Morbidity n, (%)     
With Comorbidities 7,902 (11.77) 64,541 (1.76) 72,443 (7.97) <.0001 
Without Comorbidities 59,222 (88.23) 3,602,094 (98.24) 3,661,316 (92.03)  
Mortality n, (%)     
Died 515 (0.77) 10,408 (0.28) 10,923 (0.29) <.0001 
Alive  66,599 (99.23) 3,656,010 (99.72) 3,722,609 (99.71)  
Prematurity n, (%)     
Premature  27,064 (40.32) 270,550 (7.38) 297,614 (7.97) <.0001 
Non-Premature  40,060 (59.68) 3,396,086 (92.62) 3,436,146 (92.03)  
HCUP KID, Kid’s Inpatient Database 2012. All analyses were weighted to account for the complex probability sampling 
of the dataset. $Other Race, Asian/Pacific Islander; Native American; unspecified; £SGA, small for gestational age; ¥LGA, 





Table IV.2. Continued.  
Variables Hypoglycemic  Non-Hypoglycemic Total P Value  
Unweighted sample n 51,880  1,055,693 1,107,573  
Weighted population size n 67,124  3,666,636 3,733,760  
Delivery Mode n, (%)     
Cesarean Section 29,903 (44.55) 114,2704 (31.16) 117,2607 (31.41) <.0001 
Normal Delivery   37,221 (55.45) 2,523,931 (68.84) 2,561,152 (68.59)  
Mothers’ Diabetic Status n, (%)     
Diabetic 20,674 (30.80) 259,243 (7.07) 279,917 (7.50) <.0001 
Non-Diabetic 46,450 (69.20) 3,407,393 (92.93) 3,453,843 (92.50)  
Admission Day n, (%)     
Weekday 53,029 (79.00) 2,929,102 (79.89) 2,982,131 (79.87) <.0001 
Weekend  14,095 (21.00) 737,532 (20.11) 751,627 (20.13)  
Scheduled Admission Status n, %     
Scheduled Delivery  164 (0.24) 8,391 (0.23) 8,555 (0.23) <.0001 
Non Scheduled Delivery 6,6874 (99.76) 3,654,687 (99.77) 3,721,561 (99.77)  
Emergency* Dept. Service n, (%)     
Serviced  88 (0.001) 2,214 (0.001) 2,302 (0.06) <.0001 
Not Serviced  67,037 (99.9) 3,664,422 (99.9) 3,731,459 (99.94)  
History of Sub/alc. Abuse n, (%)     
Indicated   1,566 (2.33) 27,584 (0.75) 29,150 (0.78) <.0001 
Not-Indicated 65,558 (97.67) 3,639,052 (99.25) 3,704,610 (99.22)  
HCUP KID, Kid’s Inpatient Database 2012. All analyses were weighted to account for the complex probability sampling 







Table IV.3. Contextual Level Characteristics of Neonates with Hypoglycemia 
Variables Hypoglycemic  Non-Hypoglycemic Total P Value  
Unweighted sample n 51,880  1,055,693 1,107,573  
Weighted population size n 67,124  3,666,636 3,733,760  
Type of Insurance      
Medicaid 30,843 (46.04) 1,695,905 (46.38) 1,726,748 (46.37) <.0001 
Medicare 276 (0.41) 12,991 (0.36) 1,326,7 (0.36)  
Private insurance 31,799 (47.46) 1,687,688 (46.15) 1,719,487 (46.18)  
Other % 4,081 (6.09) 259,998 (7.1) 264,079 (7.09)  
Teaching status n, (%)     
Teaching  38,050 (56.69) 1,813,077 (49.6) 1,851,127 (49.58) <.0001 
Non-Teaching  29,074 (43.31) 1,853,559 (50.55) 1,882,633 (50.42)  
Bed Size n, (%)     
Small (1-99) 6,187 (9.22) 406,305 (11.08) 412,492 (11.05) <.0001 
Medium (100-399) 16,811 (25.04) 935,351 (25.51) 952,162 (25.50)  
Large (≥ 400) 44,126 (65.74) 2,324,980 (63.41) 2,369,106 (63.45)  
Ownership n, (%)     
Private  49,286 (73.43) 2,651,655 (72.32) 2,700,941 (72.34) <.0001 
Public 17,838(26.57) 1,014,981 (27.68) 1,032,819 (27.66)  
Neighborhood Income#     
1st Quartile (1 - 38,999) 18,405 (27.92) 1,023,540 (28.41) 1,041,945 (28.40) <.0001 
2nd Quartile (39,000 - 47,999) 15,945 (24.19) 886,723 (24.61) 902,668 (24.61)  
3rd Quartile (48,000 - 62,999) 16,086 (24.40) 886,738 (24.61) 902,824 (24.61)  
4th Quartile (63,000+) 15,489 (23.49) 805,520 (22.36) 821,009 (22.38)  
HCUP KID, Kid’s Inpatient Database 2012. All analyses were weighted to account for the complex probability 
sampling of the dataset. %Other Insurance = Self-pay, No charge, Other; #Income =Median Household Income for 





Table IV.3. Continued. 
Variables Hypoglycemic  Non-Hypoglycemic Total P Value  
Unweighted sample n 51,880  1,055,693 1,107,573  
Weighted population size n 67,124  3,666,636 3,733,760  
Admission Season     
January-March 15,388 (22.93) 880,221 (24.01) 895,609 (23.99) <.0001 
April-June 16,034 (23.89) 889,119 (24.25) 905,153 (24.25)  
July-September 18,080 (26.94) 975,669 (26.61) 993,749 (26.62)  
October-December 17,605 (26.23) 920,905 (25.12) 938,510 (25.14)  
Hospital Location     
 Rural 5,576 (8.31) 441,988 (12.05) 447,564 (11.99) <.0001 
 Urban  61,548 (91.69) 3,224,647 (87.95) 3,286,195 (88.01)  
Hospital Region      
Northeast 11,645 (17.35) 603,344 (16.45) 614,988 (16.47) <.0001 
Midwest 14,847 (22.12) 779,609 (21.26) 794,456 (21.28)  
South 25,813 (38.46) 1,395,779 (38.07) 1,421,592 (38.07)  
West 14,820 (22.08) 887,905 (24.22) 902,725 (24.18)  
HCUP KID, Kid’s Inpatient Database 2012. All analyses were weighted to account for the complex probability 











Table IV.4. Odds Ratio, 95% CIs, and P Values from Bivariate Random Intercept Models for 
Individual Level and Contextual Level Risk Factors 
Variables  OR*  95% CI P value 
Male 1.3 1.273 - 1.313 <.0001 
Black  1.1 1.052 - 1.107 <.0001 
Hispanic  0.8 0.769 - 0.812 0.0002 
Other$ 0.8 0.820 - 0.869 <.0001 
Morbidity 2.7 2.573 - 2.734 <.0001 
SGA£ 9.6 9.409 - 9.718 <.0001 
LGA¥ 2.9 2.812 - 2.945 <.0001 
Premature 7.0 6.782 - 7.150 <.0001 
Cesarean Section 1.9 1.795 - 1.852 <.0001 
Diabetic 5.6 5.455 - 5.648 <.0001 
Substance 3.2 2.971 - 3.343 <.0001 
Scheduled Delivery 0.8 0.635 - 0.920 0.0046 
Weekend 1.0 1.022 - 1.062 <.0001 
Emergency#  2.2 1.646 - 2.833 0.0018 
2nd Quartile (39,000 - 47,999) 0.9 0.970 - 1.017 0.0833 
3rd Quartile (48,000 - 62,999) 0.9 0.931 - 0.978 0.1898 
4th Quartile (63,000+) 0.9 0.944 - 0.997 0.0302 
Lower Income  1.0 1.018 - 1.058 0.0001 
Midwest€  1.2 1.123 - 1.190 <.0001 
South 1.1 1.111 - 1.172 <.0001 
West 1.1 1.081 - 1.135 <.0001 
2nd Quarter Admission  1.0 0.999 - 1.045 <.0001 
3rd Quarter Admission 1.1 1.033 - 1.079 0.0291 
4th Quarter Admission 1.1 1.057 - 1.105 <.0001 
Teaching Status  1.7 1.579 - 1.865 <.0001 
Medium Bed Size (100-399)Ω 1.2 1.035 - 1.290 <.0001 
Large Bed Size (≥ 400)  1.4 1.263 - 1.549 <.0001 
Privately Owned  1.1 1.053 - 1.244 0.0016 
Urban Hospitals  2.0 1.838 - 2.242 <.0001 
Medicaid∞ 1.2 1.008 - 1.352 0.0389 
Private insurance 1.0 1.017 - 1.056 0.0002 
Other% 0.9 0.830 - 0.898 <.0001 
*OR, unadjusted odds ratio; $Other Race, Asian/Pacific Islander; Native American; Unspecified; 
£SGA, small for gestational age; ¥LGA, large for gestational age; CI, confidence interval; 
#Emergency, HCUP Emergency Department service indicator; €Northeast region used as 
reference; Ω Small (1-99) used as reference; ∞Medicare used as reference; %Other Insurance, 




Table IV.5. Odds Ratio, 95% CIs, and P Values from Model 2 that Indicate the Relationship 
between Individual Level Predictors and Neonatal Hypoglycemia 
Variables  OR*  95% CI P value 
Female 0.8 0.81 - 0.85 <.0001 
Black  1.0 0.94 - 1.09 <.0001 
Hispanic  0.8 0.78 - 0.83 0.0003 
Other$ 0.9 0.84 - 0.90 <.0001 
Morbidity 2.6 2.49 - 2.66 <.0001 
SGA£ 3.9 3.82 - 3.98 <.0001 
LGA¥ 2.8 2.76 - 2.92 <.0001 
Premature 1.9 1.87 - 1.99 <.0001 
Cesarean Section 1.4 1.38 - 1.44 <.0001 
Diabetic 2.0 1.95 - 2.04 <.0001 
Substance 1.2 1.10 - 1.25 <.0001 
Scheduled Delivery 0.8 0.66 - 0.99 0.0473 
Weekend 1.0 1.01 - 1.06 0.0075 
Emergency#  1.4 1.02 - 1.82 0.0370 
+NH, Neonatal hypoglycemia;*OR, adjusted odds ratio; $Other Race, Asian/Pacific Islander; 
Native American; £SGA, small for gestational age; ¥LGA, large for gestational age; CI, 








Table IV.6. Odds Ratio, 95% CIs, and P Values from Model 3 that Indicate the Relationship 
Between Individual and Contextual Level Predictors and Neonatal Hypoglycemia 
Variables  OR*  95% CI P value 
Male 1.2 1.18 - 1.23 <.0001 
Black  1.0 0.90 - 1.06 0.5739 
Hispanic  0.7 0.61 - 0.80 <.0001 
Other$ 0.8 0.78 - 0.91 <.0001 
Morbidity 5.0 4.63 - 5.40 <.0001 
SGA£ 9.7 9.25 - 10.27 <.0001 
LGA¥ 3.1 2.86 - 3.34 <.0001 
Premature 3.8 3.44 - 4.15 <.0001 
Cesarean Section 1.5 1.50 - 1.59 <.0001 
Diabetic 5.1 4.81 - 5.41 <.0001 
Substance 2.1 1.92 - 2.29 <.0001 
Scheduled Delivery 1.0 0.79 - 1.57 0.5470 
Weekend 1.1 1.03 - 1.08 <.0001 
Emergency#  1.5 1.10 - 2.00 0.0106 
2nd Quartile (39,000 - 47,999) 1.0 0.94 - 1.05 0.7809 
3rd Quartile (48,000 - 62,999) 0.9 0.90 - 1.04 0.4293 
4th Quartile (63,000+) 1.0 0.93 - 1.10 0.8046 
Midwest€  0.9 0.85 - 1.10 0.8046 
South 0.9 0.87 - 1.10 0.4293 
West 0.9 0.87 - 1.09 0.7809 
2nd Quarter Admission  1.0 1.00 - 1.06 0.0002 
3rd Quarter Admission 1.1 1.02 - 1.13 0.0040 
4th Quarter Admission 1.1 1.05 - 1.15 0.0747 
Teaching Status  1.2 1.10 - 1.34 0.0001 
Medium Bed Size (100-399)Ω 1.1 0.92 - 1.24 0.2939 
Large Bed Size (≥ 400)  1.1 0.94 - 1.23 0.4090 
Privately Owned  1.0 0.90 - 1.14 0.8254 
Urban Hospitals  1.4 1.21 - 1.52 <.0001 
Medicaid∞ 0.9 0.67 - 1.09 0.2124 
Private insurance 0.9 0.68 - 1.13 0.3010 
Other% 0.8 0.60 - 1.04 0.2124 
+NH, Neonatal hypoglycemia;*OR, unadjusted odds ratio; $Other Race, Asian/Pacific Islander; 
Native American; £SGA, small for gestational age; ¥LGA, large for gestational age; CI, 
confidence interval; #Emergency, HCUP Emergency Department service indicator; €Northeast 
region used as reference; Ω Small (1-99) used as reference; ∞Medicare used as reference; %Other 






The overall purpose of this dissertation was to gain a better understanding of the 
healthcare outcomes and resources utilizations related to neonates with hypoglycemia. To 
achieve this overarching goal, a series of interrelated studies with multiple sub-goals were 
carried out. The first goal of this dissertation was to conduct a systematic review in order to 
investigate whether previous studies only focused on clinical risk factors or included a broader 
health service-related contextual risk factors in assessing the determinants of neonatal 
hypoglycemia. The second purpose was to identify the key factors associated with increased 
hospital cost related to neonatal hypoglycemia in the United States. Lastly, the final purpose of 
the dissertation was to construct multi-level models that include individual-level and contextual-
level characteristics in order to predict neonatal hypoglycemia in diabetic and non-diabetic 
mothers. In order to summarize the findings within this dissertation the hypotheses from the 
Chapter I are revisited: 
Aim 1 - Hypothesis: In the literature, all studies will focus on the individual level characteristics 
as determining risk factors for neonatal hypoglycemia.   
Findings: The hypothesis related to the first aim was confirmed as the evidence demonstrated 
that the studies included in the systematic review mainly focused on the clinical risk factors of 
neonatal hypoglycemia. Although infant-related and mother-related risk factors were specified in 
these studies broader health service-related contextual risk factors were not included.  
Aim 2 - Hypothesis 2.1: Healthcare outcome measures including length of stay, comorbidities, 
mortality, prematurity, number of procedures, hospital bed size, chronic conditions, and hospital 




Findings: This hypothesis was supported by the evidence that the indicated healthcare outcome 
measures were significantly associated with increased hospital cost. To maximize the accuracy 
of the cost estimation and model prediction, our study, for the first time, used actual cost by 
converting the total hospital charge to total hospital cost using the cost to charge ratio provided 
by the HCUP KID database. 
Aim 2 - Hypothesis 2.2: Neonates with hypoglycemia will consume a higher percentage of 
resources associated with hospital births while accounting for a smaller percentage of 
hospitalization.  
Findings: This hypothesis was supported by the evidence that neonates with hypoglycemia 
consumed 11% of resources associated with hospital births while accounting for only 1.5% of 
hospitalization. Although healthcare resource utilization of hypoglycemia has been adequately 
addressed in the adult population, this topic has not been studied in neonates with hypoglycemia. 
As a result, these findings will provide important information to help allocate resources 
efficiently. 
Aim 3 – Hypothesis 3.1: Infants born from diabetic mothers have significantly higher chance of 
developing hypoglycemia compared to those born from non-diabetic mothers.  
Findings: This hypothesis was confirmed by the strong association found between neonatal 
hypoglycemia and diabetic mothers. Statistically significant associations were observed both in 
the bivariate random intercept model (OR 5.6) and multivariate model (OR 5.1). 
Aim 3 – Hypothesis 3.2: The addition of the contextual factors will enhance the predictive power 
of the model that will be constructed to predict neonatal hypoglycemia in diabetic and non-




Findings: This hypothesis was confirmed by the findings of the investigation. The calculations 
form the -2 log likelihood ratio test indicated that the addition of the contextual variables 
improved the final predictive model. In addition, the magnitudes of the odds ratios on many of 
the variables in model 2 has also shown a significant increase in model 3. This magnifies the 
importance of using border environmental risk factors in health services research. 
Summary and Policy Implications  
 
 The systematic review included in this dissertation (Project I) provided an important 
synthesis of the available data on current neonatal hypoglycemia literature. Project I determined 
that there is evidence supporting the clinical importance of giving attention to infants of diabetic 
mothers. However, the systematic review also determined that previous neonatal hypoglycemia 
studies had been solely focused on clinical or individual level risk factors. The infant-related 
clinical risk factors identified in Project I were small for gestational age, large for gestational 
age, macrosomia, prematurity, lower cord blood glucose, Ponderal Index, and male sex. In 
addition, ethnic origin, diabetes diagnosed prior to 28 weeks of gestation, pre-pregnancy BMI 
≥25 kg/m2, hyperglycemia, blood glucose, maternal diabetes type, and material HbA1c were also 
identified as mother-related clinical risk factors. As such, the project identified the need to 
include a broader contextual level risk factors in assessing the determinants of neonatal 
hypoglycemia.  
 Project II sought to determine the overall hospital cost estimates in neonates with 
hypoglycemia and to identify predictors of increased hospital cost. Since previous studies have 
focused on estimations of the economic cost of hypoglycemia in the adult population44-49, Project 
II is the first study providing an empirical estimate of the hospital cost of neonatal hypoglycemia 




cost, Project II used cost to charge ratio to covert total charge to total cost. Furthermore, Project 
II determined that medium and large hospital bed sizes, length of stay, teaching hospitals, 
composite neonatal comorbidities, prematurity, occurrence of chronic conditions, and mortality 
as independent predictors of increased hospital cost associated with neonatal hypoglycemia. 
Lastly, Project II demonstrated that neonates with hypoglycemia consumed 11% of resources 
associated with hospital births while accounting for only 1.5% of hospitalization. Although 
Project II encompassed the investigation of the resource utilization, further research is needed to 
explore longitudinal trends of hospital cost and their variation among different patient and 
hospital characteristics.  
 Project III focused on the identification of individual and contextual level risk factors 
among diabetic and non-diabetic mothers using multilevel modeling scheme. Project III 
determined that 30% of neonates were born from diabetic mothers compared to 7% born from 
non-diabetic mothers and that 20% of the variability in the rate of neonatal hypoglycemia is 
accounted by the hospitals. Furthermore, Project III determined that neonates had more than 5-
fold increased risk of developing hypoglycemia. Lastly, project III determined that male sex, 
Hispanic race, Asian/Pacific and Native Americans race, morbidity, small for gestational age, 
large for gestational age, prematurity, delivery by caesarian section, history of substance/alcohol 
abuse, scheduled delivery, emergency service use, urban hospitals, and teaching hospitals as 
significant predictors neonatal hypoglycemia. In Project III the most robust association was 
found the between the individual level risk factors and neonatal hypoglycemia. Future research 
should focus on the long term clinical significance of neonatal hypoglycemia by including a 




 Neonatal hypoglycemia is the most frequently encountered metabolic disorder of 
newborn infants and has been linked to various adverse health outcomes4,5 including neurological 
damage and death.1,49 The results of the investigations within this dissertation estimated the total 
hospital cost and identified predictors of increased cost related to neonatal hypoglycemia for the 
first time. With the current increase in the overall healthcare cost in the United States, there is a 
strong interest to enhance efficacy through reform and system improvement.50,158 A better 
understanding of total cost estimates and factors associated with increased hospital cost is 
important to help hospitals improve the efficiency of the care they provide and to decrease costs 
while maintaining high quality of care. Furthermore, the current dissertation identified the key 
individual and contextual level risk factors that can help neonatal care providers create triage 
treatment system to identify hypoglycemic neonates more quickly and efficiently. Hospitals 
across the United States should develop, therefore, a more effective method and devise 
management strategies to identify fetuses from diabetic mothers so that intervention during the 
neonatal period can be made. In addition, in the current dissertation urban and teaching hospital 
were significantly associated with neonatal hypoglycemia. Although one can argue that focusing 
on the mothers who are coming to these facilities is more important in terms of preventing 
neonatal hypoglycemia, the quality of services in these facilities could also be a significant 
factor. As neonates with asymptomatic hypoglycemia could easily be neglected of proper 
care16,41,77,121, the quality of neonatal care provided by hospitals is crucial to identify these 
subgroups. As a result, the processes of care in urban and teaching hospitals should be carefully 
scrutinized with regard to neonatal health outcomes. Although hypoglycemia is the most 
common metabolic disorder of the newborn, with proactive prenatal care, proper case 
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ICD-9-CM/ PRCCS/ DXCCS/ DRG24 
Neonatal Hypoglycemia  775.6 (ICD-9-CM) 
Large for Gestational Age 766.1 (ICD-9-CM) 
Small for Gestational Age 764.0, V21.30- V21.35 (ICD-9-CM) 
Prematurity 386, 387, 388, 375 (DRG24) 
History of Alcohol/Substance Abuse 660, 661 (DXCCS); 52,433,521,523 (DRG24) 
Complicated Pregnancy  219 (DXCCS) 
Delivery by  
Cesarean Section 
669.7; V3001(ICD-9-CM)/ 134, 
134,740,741,742,743,744,745,746,747,748,749 (PRCCS)/ 
370, 371 (DRG24) 
Indicator of Diabetic Status  
(Type I, Type II, Gestational)  
250.01-250.93, 775.0, 648.03, 648.83 (ICD-9-CM)/ 49, 
50, 186 (DXCCS)/295 (DRG24) 
Comorbidities   
Jitteriness 796.9 (ICD-9-CM) 
Hypotonia 781.3 (ICD-9-CM) 
Lethargy 780.7 (ICD-9-CM) 
Irritability 799.22 (ICD-9-CM) 
Apnea 786.03 (ICD-9-CM) 
Tachypnea 786.06 (ICD-9-CM) 
Poor feeding 783.3 (ICD-9-CM) 
Hypothermia 991.6 (ICD-9-CM)  
Sepsis 995.91, 771.81 (ICD-9-CM)  
Seizures 345.0-345.9 (ICD-9-CM) 
Neurodevelopmental Delay 315.0-315.9 (ICD-9-CM) 
ICD-9-CM= International classification of diseases, 9th version; PRCCS= Clinical classification software 
category for all procedures; DRG24= Diagnostic related groups, version 24; DXCCS=Clinical classifications 






Appendix B: Single-level versus Multi-level Models 
 
Let us assume that 𝑌 is neonatal hypoglycemia with binary outcome which follows the 
Bernoulli distribution 𝑌 ~ Bin (1, π). Equation 1 indicate a single-level logistic regression where 
i =1…𝐼𝑗 is the individual level variable, j= 1…J is the contextual level variable, conditional on 
the risk factor for neonatal hypoglycemia 𝑥 (e.g. prematurity). Ordinary logistic regression 
model (equation 1) assumes individual level random errors 𝑒𝑖𝑗 are independent with moments E 
(𝑒𝑖𝑗) = 0 and Var (𝑒𝑖𝑗) = 𝜎𝑒
2=𝜋𝑖𝑗(1 − 𝜋𝑖𝑗).
159 Equation 2 indicates the probability function of the 
outcome variable and it has the 𝑖𝑗 subscripts to show that that individual level factors are nested 
within the contextual level factors (i.e. the subjects within hospitals). However, this model is 
single-level because it does not contain contextual level effects.   
 To extend the single-level model into multi-level analysis, we add design level variables 
to equation 1 so that each higher-level unit has its own intercept in the model (equation 3).160-162 
In this case, the hospital intercept is treated as random effect 𝛼𝑗  (j=1….J). This leads to a random 
intercept model (equation 4) which is the combination of a grand mean (𝛼) and a deviation from 
that mean (𝑢𝑗). The random variable 𝑢𝑗  is assumed to be normally distributed 𝑢𝑗  ~ N (0, 𝜎𝑢
2) and 
independent  of the single level random error 𝑒𝑖𝑗.   
The model in equation 4 is a multi-level logistic regression model with two levels of 
hierarchy. At level 1, outcome is expressed as the sum of an intercept for the patient’s hospital 
and the patient’s risk factor. At level 2, the hospital level intercepts as the sum of an overall 
mean and the random deviations from that mean are specified. Equation 5 is a hierarchical/mixed 
model because it has both fixed effects (α, β) and random effects(𝑢𝑗). However, equation 5 has 





Single-Level Logistic Regression Model 








exp( 𝛼 +  𝛽𝑥𝑖𝑗)




Random Intercept and Level-1 Fixed Effects  
logit(𝜋𝑖𝑗) = 𝛼𝑗 + 𝛽𝑥𝑖𝑗 Eq.3 
logit(𝜋𝑖𝑗) = 𝛼𝑗 + 𝛽𝑥𝑖𝑗  
𝛼𝑗 = 𝛼 + 𝑢𝑗 Eq.4 
logit(𝜋𝑖𝑗) = 𝛼 +  𝑢𝑗 +  𝛽𝑥𝑖𝑗 Eq.5 
 
Random Intercept and Level-1 + Level-2 Fixed Effects 
logit(𝜋𝑖𝑗) = 𝛼𝑗 + 𝛽𝑥𝑖𝑗 
𝛼𝑗 = 𝛼 + 𝛾𝑧𝑗 +  𝑢𝑗 
Eq.6 
logit(𝜋𝑖𝑗) = 𝛼 + 𝛾𝑧𝑗 +  𝑢𝑗 +  𝛽𝑥𝑖𝑗 Eq.7 
 
As the objective of the current study is to also see the effects of contextual level 
attributes, a hospital level predictors (e.g. z for teaching status) should be included in equation 4. 
Equation 6 now indicates that the intercept 𝛼𝑗 is a linear combination of a grand mean (𝛼), 
hospital fixed effect (𝛾), and hospital foxed effect (𝑢𝑗). Equation 7 is the final mathematical 
model that contain the individual level and hospital level fixed effects.  For the purpose of 
simplicity, during the model building process, only one individual and one hospital level 
variables were included. However, in the actual analysis multiple individual and hospital or 
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